Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
β subunit of RNA polymerase
Overview
| Protein Change | Nucleotide Change | Mechanism | Organism | Resistance To | Database | Validation Status |
|---|---|---|---|---|---|---|
| D473N | - | - | Listeria monocytogenes | rifampicin | Reslit | Candidate |
| D473G | - | - | Listeria monocytogenes | rifampicin | Reslit | Candidate |
| G479D | - | - | Listeria monocytogenes | rifampicin | Reslit | Candidate |
| H483Y | - | - | Listeria monocytogenes | rifampicin | Reslit | Candidate |
| H483L | - | - | Listeria monocytogenes | rifampicin | Reslit | Candidate |
| I528F | - | - | Listeria monocytogenes | rifampicin | Reslit | Candidate |
| S530Y | - | - | Listeria monocytogenes | rifampicin | Reslit | Candidate |
| D516V | - | Mycobacterium tuberculosis, Escherichia coli, Mycobacterium smegmatis, Rhodococcus equi, Mycobacterium gastri | rifampicinrifampicin|ethambutolrifampicin|rifabutin+1 more | Reslit | Candidate | |
| S492L | - | - | Escherichia coli | rifampicin | Reslit | Candidate |
| V176F | - | - | Mycobacterium tuberculosis | rifampicinrifampicin|rifabutin | Reslit | Candidate |
| D516E | - | - | Mycobacterium tuberculosis, Mycobacterium smegmatis | rifampicinrifabutin | Reslit | Candidate |
| S522L | single resistance variant | Mycobacterium tuberculosis, Mycobacterium smegmatis, Vibrio vulnificus | rifampicinrifampicin|rifabutin | ReslitCard Database | Candidate | |
| H526P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| K527Q | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L521P | - | - | Mycobacterium bovis | rifampicin | Reslit | Candidate |
| H481N | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus, Staphylococcus epidermidis | rifampicinvancomycinteicoplanin+1 more | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate | |
| S416F | - | - | Mycobacterium ulcerans | rifampicin | Reslit | Candidate |
| H420Y | - | - | Mycobacterium ulcerans | rifampicin | Reslit | Candidate |
| S531L | disrupted the intermolecular hydrogen bond between wild-type Ser531 and the RIF molecule, reduces susceptibility, disorders the RIF-binding pocket upon RMP binding and therefore reduces the binding affinity for RMP | Mycobacterium tuberculosis, Mycobacterium simiae, Mycobacterium smegmatis, Rhodococcus equi, Escherichia coli, Mycobacterium avium, Salmonella enterica, Mycobacterium bovis | rifampicinrifampicin|rifabutinrifabutin | Reslit | Candidate | |
| H526Y | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Mycobacterium tuberculosis, Escherichia coli, Mycobacterium smegmatis, Rhodococcus equi, Photorhabdus luminescens, M. tuberculosis, Shigella sonnei | rifampicinrifampicin|rifabutin|rifapentinerifampicin|rifabutin+2 more | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate | |
| I517M | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| V466A | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| D461N | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| H471N | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| H471L | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| H471Y | - | - | Chlamydia trachomatis | rifampicinrifampicin|rifalazil | Reslit | Candidate |
| A467T | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| Q513L | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Escherichia coli, Mycobacterium tuberculosis, Shigella sonnei | rifampicin|rifabutin|rifapentinerifampicinrifamycins | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate | |
| Q513P | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Escherichia coli, Mycobacterium tuberculosis, Shigella sonnei | rifampicin|rifabutin|rifapentinerifampicinrifamycins | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate | |
| D516N | - | - | Escherichia coli, Mycobacterium smegmatis, Mycobacterium tuberculosis | rifampicin|rifabutin|rifapentinerifampicin | Reslit | Candidate |
| S522F | - | Escherichia coli | rifampicin|rifabutin|rifapentinerifampicin | Reslit | Candidate | |
| R529C | - | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Escherichia coli, Shigella sonnei | rifampicin|rifabutin|rifapentinerifampicinrifamycins | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate |
| S531F | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Escherichia coli, Mycobacterium tuberculosis, Mycobacterium smegmatis, Mycobacterium gastri, Shigella sonnei | rifampicin|rifabutin|rifapentinerifampicinrifamycins | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate | |
| T563P | - | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Escherichia coli, Shigella sonnei | rifampicin|rifabutin|rifapentinerifampicinrifamycins | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate |
| P564L | - | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Escherichia coli, Photorhabdus luminescens, Mycobacterium smegmatis, Shigella sonnei | rifampicin|rifabutin|rifapentinerifampicinrifampicin|rifamycins | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate |
| I572F | confer resistance to rifampicin and a fitness advantage in the absence of rifampicin at 42.2°C in DM25, Target modification, DNA-directed RNA polymerase subunit beta RpoB | Escherichia coli, Mycobacterium tuberculosis, Shigella sonnei | rifampicin|rifabutin|rifapentinerifampicinrifamycins | ReslitResFinder DatabaseReference Gene Catalog | Candidate | |
| R687H | - | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Escherichia coli, Shigella sonnei | rifampicinrifamycins | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate |
| V146F | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Mycobacterium tuberculosis, Escherichia coli, Shigella sonnei | rifampicinrifabutinrifamycins | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate | |
| G438G | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q510H | - | - | Mycobacterium tuberculosis, Mycobacterium smegmatis | rifampicin | Reslit | Candidate |
| H511Y | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L511P | - | Mycobacterium tuberculosis, Mycobacterium smegmatis | rifampicinrifabutin | Reslit | Candidate | |
| D516G | DNA-directed RNA polymerase subunit beta RpoB | Mycobacterium tuberculosis, Escherichia coli, Mycobacterium smegmatis, Salmonella enterica, Shigella sonnei, E. coli, Pseudomonas aeruginosa, Pseudomonas fluorescens | rifampicinrifabutin | ReslitReference Gene Catalog | Candidate | |
| D516Y | - | Mycobacterium tuberculosis, Escherichia coli | rifampicinrifabutin | Reslit | Candidate | |
| H526N | - | Mycobacterium tuberculosis, Escherichia coli, Mycobacterium smegmatis, Rhodococcus equi, Mycoplasma faucium | rifampicinrifabutin | Reslit | Candidate | |
| H526R | had hydrogen bond contact with and electrostatic attraction to the RIF molecule | Mycobacterium tuberculosis, Mycobacterium smegmatis, Rhodococcus equi | rifampicinrifabutin | Reslit | Candidate | |
| H526D | disrupted the intermolecular hydrogen bond between wild-type His526 and the RIF molecule | Mycobacterium tuberculosis, Escherichia coli, Mycobacterium smegmatis, Rhodococcus equi, Mycobacterium gastri | rifampicinrifampicin|rifabutinvancomycin | Reslit | Candidate | |
| H526C | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| H526S | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H526L | disrupted the intermolecular hydrogen bond between wild-type His526 and the RIF molecule, DNA-directed RNA polymerase subunit beta RpoB | Mycobacterium tuberculosis, Escherichia coli, Mycobacterium smegmatis, Salmonella enterica, Shigella sonnei | rifampicin | ReslitReference Gene Catalog | Candidate | |
| S526A | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S531Y | - | - | Mycobacterium tuberculosis, Mycobacterium avium, Mycobacterium bovis | rifampicin | Reslit | Candidate |
| S531W | - | Mycobacterium tuberculosis, Mycobacterium smegmatis, Rhodococcus equi, Mycobacterium avium | rifampicinrifampicin|rifabutin | Reslit | Candidate | |
| E562L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| P564S | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| I572L | - | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Mycobacterium tuberculosis, Escherichia coli, Mycobacterium smegmatis, Shigella sonnei | rifampicinrifamycins | ReslitResFinder DatabaseReference Gene Catalog | Candidate |
| P622Q | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| E641E | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| V642A | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| P646S | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| P646L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| F505L | - | single resistance variant | Mycobacterium tuberculosis | rifabutinrifampicin | ReslitCard Database | Candidate |
| S512G | - | Mycobacterium tuberculosis | rifabutinrifampicin | Reslit | Candidate | |
| V144M | - | - | Mycobacterium tuberculosis | rifabutin | Reslit | Candidate |
| Q148H | - | - | Mycobacterium tuberculosis | rifabutin | Reslit | Candidate |
| H481Y | increased vancomycin resistance, confers resistance to rifampicin, Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus, Staphylococcus epidermidis, Mycobacterium tuberculosis, Staphylococcus lugdunensis, Staphylococcus pseudintermedius, Streptococcus pyogenes | rifampicinvancomycinrifampicin|vancomycin|daptomycin | ReslitResFinder DatabaseReference Gene Catalog | Candidate | |
| L466S | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus, Staphylococcus epidermidis | rifampicinvancomycinteicoplanin+1 more | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate | |
| S529L | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus, Staphylococcus epidermidis | rifampicintedizolid|linezolidrifampicin|vancomycin|daptomycin | ReslitResFinder DatabaseReference Gene Catalog | Candidate | |
| A477D | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicinvancomycindaptomycin+1 more | ReslitResFinder DatabaseReference Gene Catalog | Candidate | |
| V850A | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| M1249I | - | - | Brucella melitensis | rifampicin | Reslit | Candidate |
| S467F | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| H502Y | - | multiple resistance variants, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Clostridium difficile, Clostridioides difficile, Clostridium ljungdahlii | rifampicin|rifaximinrifampicinrifaximin | ReslitCard DatabaseReference Gene Catalog | Candidate |
| H502N | single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Clostridium difficile, Mycobacterium tuberculosis, Clostridioides difficile, Clostridium ljungdahlii | rifampicin|rifaximinrifampicinrifamycins | ReslitCard DatabaseReference Gene Catalog | Candidate | |
| H502R | - | DNA-directed RNA polymerase subunit beta RpoB | Clostridium difficile, Clostridioides difficile | rifampicin|rifaximinrifaximin | ReslitReference Gene Catalog | Candidate |
| R505K | single resistance variant, multiple resistance variants, DNA-directed RNA polymerase subunit beta RpoB | Clostridium difficile, Mycobacterium tuberculosis, Clostridioides difficile, Clostridium ljungdahlii | rifampicin|rifaximinrifampicinrifamycins+1 more | ReslitCard DatabaseReference Gene Catalog | Candidate | |
| S488T | - | single resistance variant | Clostridium difficile, Clostridium ljungdahlii | rifampicin|rifaximinrifampicin | ReslitCard Database | Candidate |
| I548M | multiple resistance variants | Clostridium difficile, Clostridioides difficile, Clostridium ljungdahlii | rifampicin|rifaximinrifampicin | ReslitCard Database | Candidate | |
| D435Y | single resistance variant, multiple resistance variants | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate | |
| D435G | single resistance variant | Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium smegmatis | rifampicinrifabutincapreomycin+1 more | ReslitResFinder DatabaseCard Database | Candidate | |
| L452P | single resistance variant | Mycobacterium tuberculosis, Mycobacterium smegmatis, Mycobacterium bovis | rifampicinrifampicin|rifabutin | ReslitResFinder DatabaseCard Database | Candidate | |
| I1106T | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitCard Database | Candidate |
| S548F | - | - | Neisseria meningitidis | rifampicin | Reslit | Candidate |
| H552R | - | - | Neisseria meningitidis | rifampicin | Reslit | Candidate |
| H552N | - | Neisseria meningitidis, Neisseria gonorrhoeae | rifampicin | Reslit | Candidate | |
| H552L | - | - | Neisseria meningitidis | rifampicin | Reslit | Candidate |
| H552Y | - | - | Neisseria meningitidis | rifampicin | Reslit | Candidate |
| S557F | - | - | Neisseria meningitidis | rifampicin | Reslit | Candidate |
| D542V | - | - | Neisseria meningitidis | rifampicin | Reslit | Candidate |
| D542N | - | - | Neisseria meningitidis | rifampicin | Reslit | Candidate |
| G560S | - | - | Neisseria meningitidis | rifampicin | Reslit | Candidate |
| Q510P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L511V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H499R | - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate |
| H516Y | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L531V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D516F | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L533P | did not significantly change the intermolecular interaction between RpoB and RIF, Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Mycobacterium tuberculosis, Mycobacterium smegmatis, Escherichia coli, Shigella sonnei | rifampicinrifamycinsrifabutin | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate | |
| P206T | - | - | Mycobacterium tuberculosis | rifampicin|rifabutin | Reslit | Candidate |
| Y314T | - | - | Mycobacterium tuberculosis | rifampicin|rifabutin | Reslit | Candidate |
| H323T | - | - | Mycobacterium tuberculosis | rifampicin|rifabutin | Reslit | Candidate |
| I569V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| I572M | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| F584S | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| V615M | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D626E | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| K972T | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D516A | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S177L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S105T | - | - | Mycobacterium tuberculosis | isoniazid | Reslit | Candidate |
| M102I | - | - | Mycobacterium tuberculosis | isoniazid | Reslit | Candidate |
| A30V | - | - | Mycobacterium tuberculosis | ethambutol | Reslit | Candidate |
| T54A | - | - | Mycobacterium tuberculosis | ofloxacin | Reslit | Candidate |
| T34I | - | - | Mycobacterium tuberculosis | ofloxacin | Reslit | Candidate |
| P496S | - | single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Clostridium difficile, Flavobacterium psychrophilum, Clostridium ljungdahlii, Clostridioides difficile | rifampicinrifamycins | ReslitCard DatabaseReference Gene Catalog | Candidate |
| D471G | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | vancomycinrifampicinrifampicin|vancomycin|daptomycin | ReslitResFinder DatabaseReference Gene Catalog | Candidate | |
| R483H | - | - | Staphylococcus aureus | vancomycin | Reslit | Candidate |
| S464P | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | vancomycinrifampicinrifampicin|vancomycin|daptomycin | ReslitResFinder DatabaseReference Gene Catalog | Candidate | |
| H526G | - | disrupted the intermolecular hydrogen bond between wild-type His526 and the RIF molecule | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S425L | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| Q489K | - | - | Clostridium difficile | rifampicin|rifaximinrifampicin | Reslit | Candidate |
| D492V | - | single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Clostridium difficile, Clostridium ljungdahlii, Clostridioides difficile | rifampicin|rifaximinrifampicinrifaximin | ReslitCard DatabaseReference Gene Catalog | Candidate |
| S450L | confers rifampicin resistance, disrupts a key intermolecular hydrogen bond between serine and RIF and introduces a hydrophobic leucine residue that causes steric hindrance, decreased drug binding affinity, increased IC 50 of both rifamycins, The rpoB S450L mutation is located in the 81-bp RIF resistance–determining region (RRDR) of the rpoB gene, multiple resistance variants, single resistance variant | Mycobacterium tuberculosis, Mycobacterium smegmatis, Rhodothermus marinus, Mycobacterium bovis, Staphylococcus aureus, Mycobacterium leprae, Mycobacterium kansasii, Escherichia coli | rifampicinrifampicin|rifabutincapreomycin | ReslitResFinder DatabaseCard Database | Candidate | |
| P454T | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H445L | single resistance variant | Mycobacterium tuberculosis, Mycobacterium bovis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate | |
| I491M | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Y564H | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| I491F | confers rifampicin resistance, single resistance variant | Mycobacterium tuberculosis, Mycobacterium leprae, Pseudomonas aeruginosa, Staphylococcus aureus, Mycobacterium smegmatis, Mycobacterium kansasii | rifampicin | ReslitResFinder DatabaseCard Database | Candidate | |
| S485F | - | - | Clostridium difficile | rifampicin | Reslit | Candidate |
| H529Y | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R518L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S531C | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S531A | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H526Q | - | - | Mycobacterium tuberculosis, Mycobacterium smegmatis | rifampicinrifabutin | Reslit | Candidate |
| S517F | - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate |
| Q518R | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| Q518L | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| D521G | - | Pseudomonas aeruginosa, Pseudomonas fluorescens | rifampicin | Reslit | Candidate | |
| H531Y | - | Pseudomonas aeruginosa, Pseudomonas fluorescens, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| H531L | - | Pseudomonas aeruginosa, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| S536F | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| L538I | - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate |
| S579F | - | Pseudomonas aeruginosa, Pseudomonas fluorescens | rifampicin | Reslit | Candidate | |
| S579Y | - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate |
| N629S | - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate |
| D636Y | - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate |
| R201H | - | DNA-directed RNA polymerase subunit beta RpoB | Neisseria gonorrhoeae | ceftriaxonecephalosporins | ReslitReference Gene Catalog | Candidate |
| A621E | - | The rpoB(A621E) mutation conferred N315ΔIP with the phenotypes of reduced susceptibility to daptomycin and hetero-VISA., single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | daptomycinvancomycin|daptomycin | ReslitCard DatabaseReference Gene Catalog | Candidate |
| Q645H | - | dysregulation of RNAP transcription activity | Staphylococcus aureus | oxacillinoxacillin|cefoxitin|imipenem | Reslit | Candidate |
| V1016E | - | - | Staphylococcus aureus | oxacillin | Reslit | Candidate |
| H1042Q | - | - | Staphylococcus aureus | oxacillin | Reslit | Candidate |
| D449N | - | - | Staphylococcus aureus | phenicols|linezolid|retapamulin|quinupristin dalfopristin | Reslit | Candidate |
| D471E | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus epidermidis, Staphylococcus aureus | rifampicindaptomycinrifampicin|vancomycin+1 more | ReslitReference Gene Catalog | Candidate | |
| S512T | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| V170F | confers rifampicin resistance, single resistance variant | Mycobacterium smegmatis, Mycobacterium tuberculosis | rifampicinrifampicin|rifabutin | ReslitResFinder DatabaseCard Database | Candidate | |
| S447L | - | - | Mycobacterium smegmatis, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H526T | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L430P | single resistance variant, multiple resistance variants | Mycobacterium tuberculosis | rifampicinrifabutin | ReslitResFinder DatabaseCard Database | Candidate | |
| F424V | - | - | Mycobacterium tuberculosis | rifampicin | ReslitResFinder Database | Candidate |
| D441F | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D441N | - | - | Mycobacterium tuberculosis, Mycobacterium leprae | rifampicin | Reslit | Candidate |
| D441V | - | - | Mycobacterium tuberculosis, Mycobacterium leprae | rifampicin | Reslit | Candidate |
| D441Y | - | Mycobacterium tuberculosis, Mycobacterium leprae | rifampicin | Reslit | Candidate | |
| H451R | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H451N | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H451Q | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H451C | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H451P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H451T | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S456F | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S456P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S456Q | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S456W | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S456Y | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| A75V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| V976M | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D1012G | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L1128Q | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D441C | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q458K | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| A467E | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| S476L | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| I517L | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| Q458L | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| A467V | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| D461E | - | - | Chlamydia pneumoniae | rifamycinsrifampicin|rifalazil | Reslit | Candidate |
| M515I | - | - | - | rifamycins | Reslit | Candidate |
| A473T | - | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate |
| H445Y | disrupts an intermolecular hydrogen bond between histidine and rifampicin and introduces an aromatic ring that sterically interferes with rifampicin binding, The rpoB H445Y mutation in Mtb is associated with an increased transcription elongation rate, single resistance variant, multiple resistance variants | Mycobacterium tuberculosis, Mycobacterium bovis, Escherichia coli, Mycobacterium smegmatis | rifampicinrifampicin|rifabutincapreomycin | ReslitResFinder DatabaseCard Database | Candidate | |
| Q432K | single resistance variant | Mycobacterium tuberculosis | rifampicinrifabutin | ReslitResFinder DatabaseCard Database | Candidate | |
| D435V | substitutes the negatively charged aspartate with a bulkier nonpolar valine residue causing steric hindrance within the rifampicin-binding pocket, increased IC 50 of both rifamycins, single resistance variant, multiple resistance variants | Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium smegmatis, Escherichia coli | rifampicinrifampicin|rifabutincapreomycin | ReslitResFinder DatabaseCard Database | Candidate | |
| H445A | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H445P | - | single resistance variant, multiple resistance variants | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| Q172R | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q432P | single resistance variant | Mycobacterium tuberculosis, Mycobacterium bovis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate | |
| E761D | - | - | Mycobacterium tuberculosis | rifampicin | ReslitResFinder Database | Candidate |
| D203E | - | Pseudomonas aeruginosa | ceftazidimeceftazidime|rifampicin | Reslit | Candidate | |
| R184H | - | Pseudomonas aeruginosa | ceftazidime | Reslit | Candidate | |
| R184C | - | Pseudomonas aeruginosa | ceftazidime | Reslit | Candidate | |
| S186F | - | Pseudomonas aeruginosa | ceftazidime | Reslit | Candidate | |
| V471E | - | Pseudomonas aeruginosa | ceftazidime | Reslit | Candidate | |
| V474E | - | Pseudomonas aeruginosa | ceftazidime | Reslit | Candidate | |
| H445R | single resistance variant | Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium smegmatis | rifampicinrifampicin|rifabutincapreomycin | ReslitResFinder DatabaseCard Database | Candidate | |
| H445D | replaces a neutral histidine with a negatively charged residue, weakening hydrogen bonding and destabilizing drug interactions, multiple resistance variants, single resistance variant | Mycobacterium tuberculosis, Mycobacterium bovis | rifampicinrifampicin|rifabutin | ReslitResFinder DatabaseCard Database | Candidate | |
| D342G | - | mutations in specific positions of the coding sequences are known to affect the binding of drugs to RNAP, leading to drug resistance | Escherichia coli | rifampicin | Reslit | Candidate |
| H553Y | - | The H553Y mutation in rpoB confers rifampin resistance., DNA-directed RNA polymerase subunit beta RpoB | Neisseria meningitidis | penicillinrifampicin | ReslitReference Gene Catalog | Candidate |
| L305P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H445S | - | single resistance variant, multiple resistance variants | Mycobacterium tuberculosis | rifampicin | ReslitCard Database | Candidate |
| H445N | single resistance variant | Mycobacterium tuberculosis, Staphylococcus aureus | rifampicin | ReslitResFinder DatabaseCard Database | Candidate | |
| S487L | single resistance variant | Staphylococcus aureus, Bacillus subtilis | rifampicincefotaxime|rifampicin | ReslitCard Database | Candidate | |
| H451D | - | - | Mycobacterium leprae, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D435F | - | single resistance variant | Mycobacterium tuberculosis, Mycobacterium bovis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| H445Q | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| R384W | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S512P | - | - | Escherichia coli, Salmonella enterica | rifampicin | Reslit | Candidate |
| Q473K | - | - | Enterococcus faecium | rifampicin | Reslit | Candidate |
| G482D | - | upregulation of a previously uncharacterized operon (prdRAB) that leads to cell membrane remodelling and cross-resistance to daptomycin through reduced binding of the antibiotic, DNA-directed RNA polymerase subunit beta RpoB | Enterococcus faecium | rifampicindaptomycindaptomycin|rifaximin | ReslitReference Gene Catalog | Candidate |
| H486Y | - | upregulation of a previously uncharacterized operon (prdRAB) that leads to cell membrane remodelling and cross-resistance to daptomycin through reduced binding of the antibiotic, DNA-directed RNA polymerase subunit beta RpoB | Enterococcus faecium | rifampicindaptomycindaptomycin|rifaximin | ReslitReference Gene Catalog | Candidate |
| S491L | - | - | Enterococcus faecium | rifampicin | Reslit | Candidate |
| H35N | - | - | Neisseria meningitidis | rifampicin | Reslit | Candidate |
| H35Y | - | - | Neisseria meningitidis | rifampicin | Reslit | Candidate |
| H35R | - | - | Neisseria meningitidis | rifampicin | Reslit | Candidate |
| S35F | - | - | Neisseria meningitidis | rifampicin | Reslit | Candidate |
| Q528L | - | - | Legionella pneumophila | rifampicin | Reslit | Candidate |
| Q528K | - | - | Legionella pneumophila | rifampicin | Reslit | Candidate |
| D531N | - | - | Legionella pneumophila, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S537F | - | - | Legionella pneumophila | rifampicin | Reslit | Candidate |
| H541Y | - | - | Legionella pneumophila | rifampicin | Reslit | Candidate |
| R544H | - | - | Legionella pneumophila | rifampicin | Reslit | Candidate |
| I545N | - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate |
| I545L | - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate |
| Q513R | - | Mycobacterium tuberculosis, Escherichia coli | rifampicin | Reslit | Candidate | |
| L531P | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| D526Y | - | - | Brucella melitensis, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D574N | - | - | Brucella melitensis, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| V154F | - | - | Brucella melitensis | rifampicin | Reslit | Candidate |
| R539S | - | - | Brucella melitensis | rifampicin | Reslit | Candidate |
| S541L | - | - | Brucella melitensis | rifampicin | Reslit | Candidate |
| D526G | - | - | Brucella melitensis, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| P574L | - | - | Brucella melitensis | rifampicin | Reslit | Candidate |
| H526E | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| G513L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L177L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D471Y | - | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus epidermidis, Staphylococcus aureus | rifampicin | ReslitResFinder DatabaseReference Gene Catalog | Candidate |
| A473S | - | - | - | rifampicin | Reslit | Candidate |
| A477S | - | - | - | rifampicin | Reslit | Candidate |
| E478D | - | - | Staphylococcus aureus | rifampicindaptomycin | Reslit | Candidate |
| I953S | - | single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | daptomycin | ReslitCard DatabaseReference Gene Catalog | Candidate |
| N474S | - | - | Streptomyces lydicus, Streptomyces spectabilis, Mycobacterium tuberculosis | streptovaricin|rifampicinrifampicinteicoplanin | Reslit | Candidate |
| S475A | - | - | Streptomyces lydicus, Streptomyces spectabilis | streptovaricin|rifampicin | Reslit | Candidate |
| T638K | - | - | Streptomyces lydicus, Streptomyces spectabilis | rifampicin | Reslit | Candidate |
| A639S | - | - | Streptomyces lydicus, Streptomyces spectabilis | rifampicin | Reslit | Candidate |
| L463I | - | - | Streptomyces lydicus, Streptomyces spectabilis | streptovaricin|rifampicin | Reslit | Candidate |
| S470N | - | - | Streptomyces lydicus, Streptomyces spectabilis | streptovaricin|rifampicin | Reslit | Candidate |
| A471S | - | - | Streptomyces lydicus, Streptomyces spectabilis | streptovaricin|rifampicin | Reslit | Candidate |
| E526K | - | - | - | rifampicin | Reslit | Candidate |
| D516T | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| G523A | - | - | Mycobacterium tuberculosis, Mycobacterium smegmatis | rifampicin | Reslit | Candidate |
| H526F | - | - | Mycobacterium tuberculosis, Mycobacterium smegmatis | rifampicin | Reslit | Candidate |
| G523E | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| G507S | - | - | Mycobacterium smegmatis, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q513V | - | - | Mycobacterium smegmatis | rifampicin | Reslit | Candidate |
| Q517H | - | - | Mycobacterium smegmatis | rifampicin | Reslit | Candidate |
| A532S | - | - | Mycobacterium smegmatis | rifampicin | Reslit | Candidate |
| V547I | - | - | Mycobacterium smegmatis | rifampicin | Reslit | Candidate |
| G507D | - | - | Mycobacterium smegmatis, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| T508H | - | - | Mycobacterium smegmatis | rifampicin | Reslit | Candidate |
| T508A | - | - | Mycobacterium smegmatis, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q513N | - | - | Mycobacterium smegmatis | rifampicin | Reslit | Candidate |
| Q513E | - | - | Mycobacterium smegmatis, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D516H | - | - | Mycobacterium smegmatis | rifampicin | Reslit | Candidate |
| L521M | - | - | Mycobacterium smegmatis | rifampicin | Reslit | Candidate |
| R529K | - | Mycobacterium smegmatis, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| D526V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q513K | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| D521A | - | - | Pseudomonas fluorescens | rifampicin | Reslit | Candidate |
| L526V | - | - | Pseudomonas fluorescens | rifampicin | Reslit | Candidate |
| H531C | - | - | Pseudomonas fluorescens, Pseudomonas aeruginosa | rifampicin | Reslit | Candidate |
| L538P | - | - | Pseudomonas fluorescens | rifampicin | Reslit | Candidate |
| L531S | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H516L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L511R | - | Mycobacterium tuberculosis, Escherichia coli | rifampicin | Reslit | Candidate | |
| T480I | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H119Y | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R135W | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S135L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D90V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q527R | - | single resistance variant | Bartonella bacilliformis, Helicobacter pylori | rifampicinrifampicin|rifabutin | ReslitCard Database | Candidate |
| H540Y | single resistance variant | Bartonella bacilliformis, Helicobacter pylori | rifampicinrifampicin|rifabutinrifabutin | ReslitCard Database | Candidate | |
| S545F | - | - | Bartonella bacilliformis | rifampicin | Reslit | Candidate |
| S588Y | - | - | Bartonella bacilliformis | rifampicin | Reslit | Candidate |
| S456L | single resistance variant | Mycobacterium leprae, Mycobacterium tuberculosis | rifampicin | ReslitCard Database | Candidate | |
| S458M | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| R505W | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| A426T | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| T400A | - | - | Mycobacterium tuberculosis | rifampicin|rifabutinrifampicin | ReslitResFinder Database | Candidate |
| H485Y | - | The H485Y mutation in rpoB confers rifampicin resistance in B. velezensis. | Bacillus velezensis | rifampicin | Reslit | Candidate |
| H485C | - | The H485C mutation in rpoB confers rifampicin resistance in B. velezensis. | Bacillus velezensis | rifampicin | Reslit | Candidate |
| H485R | - | The H485R mutation in rpoB confers rifampicin resistance in B. velezensis. | Bacillus velezensis | rifampicin | Reslit | Candidate |
| H485D | - | The H485D mutation in rpoB confers rifampicin resistance in B. velezensis. | Bacillus velezensis | rifampicin | Reslit | Candidate |
| S490L | - | The S490L mutation in rpoB confers rifampicin resistance in B. velezensis. | Bacillus velezensis | rifampicin | Reslit | Candidate |
| Q472R | - | The Q472R mutation in rpoB confers rifampicin resistance in B. velezensis. | Bacillus velezensis | rifampicin | Reslit | Candidate |
| S617F | - | The S617F mutation in rpoB confers rifampicin resistance in B. velezensis. | Bacillus velezensis | rifampicin | Reslit | Candidate |
| S526P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q135R | - | - | - | rifampicin | Reslit | Candidate |
| S531D | - | - | - | rifampicin | Reslit | Candidate |
| S531E | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S531R | - | - | - | rifampicin | Reslit | Candidate |
| S531K | - | - | - | rifampicin | Reslit | Candidate |
| S531H | - | - | - | rifampicin | Reslit | Candidate |
| R529A | - | - | - | rifampicin | Reslit | Candidate |
| R529S | - | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Escherichia coli, Shigella sonnei | rifampicinrifamycins | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate |
| R529E | - | - | - | rifampicin | Reslit | Candidate |
| S450W | - | single resistance variant | Mycobacterium tuberculosis, Mycobacterium bovis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| S450F | single resistance variant | Mycobacterium tuberculosis, Mycobacterium bovis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate | |
| H445C | single resistance variant, multiple resistance variants | Mycobacterium tuberculosis | rifampicin | ReslitCard Database | Candidate | |
| P280L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| E521K | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D595Y | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S431T | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| S441Q | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| S441L | single resistance variant, multiple resistance variants | Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium smegmatis | rifampicincapreomycin | ReslitResFinder DatabaseCard Database | Candidate | |
| H445F | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| H445G | - | single resistance variant | Mycobacterium tuberculosis, Mycobacterium bovis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| T441S | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R456T | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| G136D | - | Acinetobacter baumannii | tigecycline | Reslit | Candidate | |
| G530E | - | - | Chlamydia suis | rifampicin | Reslit | Candidate |
| D461A | - | - | Chlamydia suis | rifamycins | Reslit | Candidate |
| D479E | - | - | Helicobacter pylori | rifabutin | Reslit | Candidate |
| T593A | - | - | Helicobacter pylori | rifabutin | Reslit | Candidate |
| T593K | - | - | Helicobacter pylori | rifabutin | Reslit | Candidate |
| G595S | - | - | Helicobacter pylori | rifabutin | Reslit | Candidate |
| A451V | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitCard Database | Candidate |
| A532V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| V51I | - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate |
| L449M | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitCard Database | Candidate |
| S450Y | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate | |
| S493L | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| D516del | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L516P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| N469K | - | - | Flavobacterium columnare | rifampicin | Reslit | Candidate |
| N163K | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q432L | single resistance variant | Mycobacterium tuberculosis | rifampicinrifabutin | ReslitResFinder DatabaseCard Database | Candidate | |
| N437D | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| S523L | - | - | Francisella tularensis | rifampicin | Reslit | Candidate |
| S450X | - | - | Mycobacterium tuberculosis | rifampicinrifampicin|rifabutin | Reslit | Candidate |
| H445X | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D435X | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D435E | - | single resistance variant, multiple resistance variants | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| S491F | - | upregulation of a previously uncharacterized operon (prdRAB) that leads to cell membrane remodelling and cross-resistance to daptomycin through reduced binding of the antibiotic, mutated | Enterococcus faecium | daptomycindaptomycin|rifampicin | Reslit | Candidate |
| Q473L | - | upregulation of a previously uncharacterized operon (prdRAB) that leads to cell membrane remodelling and cross-resistance to daptomycin through reduced binding of the antibiotic | Enterococcus faecium | daptomycin | Reslit | Candidate |
| T634K | - | upregulation of a previously uncharacterized operon (prdRAB) that leads to cell membrane remodelling and cross-resistance to daptomycin through reduced binding of the antibiotic | Enterococcus faecium | daptomycin | Reslit | Candidate |
| D435H | - | single resistance variant | Mycobacterium bovis, Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| P230L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| E518D | - | - | Helicobacter pylori | rifampicin | Reslit | Candidate |
| N587S | - | - | Helicobacter pylori | rifampicin | Reslit | Candidate |
| D597N | - | - | Helicobacter pylori | rifampicin | Reslit | Candidate |
| D610N | - | - | Helicobacter pylori | rifampicin | Reslit | Candidate |
| Q468K | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus epidermidis, Staphylococcus aureus | rifampicinrifampicin|vancomycin|daptomycin | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate | |
| Q468L | - | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus epidermidis, Staphylococcus aureus | rifampicin | ReslitResFinder DatabaseReference Gene Catalog | Candidate |
| H481C | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus epidermidis | rifampicin | ReslitReference Gene Catalog | Candidate |
| S486F | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus epidermidis | rifampicin | ReslitReference Gene Catalog | Candidate |
| S486Y | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus epidermidis | rifampicin | ReslitReference Gene Catalog | Candidate |
| I527M | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus epidermidis, Staphylococcus aureus | rifampicinrifampicin|vancomycinrifampicin|teicoplanin|vancomycin | ReslitResFinder DatabaseReference Gene Catalog | Candidate | |
| R421S | - | - | Chlamydia pneumoniae | rifampicin|rifalazil | Reslit | Candidate |
| F450S | - | - | Chlamydia pneumoniae | rifampicin|rifalazil | Reslit | Candidate |
| S454F | - | - | Chlamydia pneumoniae | rifampicin|rifalazil | Reslit | Candidate |
| S476F | - | - | Chlamydia pneumoniae | rifampicin|rifalazil | Reslit | Candidate |
| L478S | - | - | Chlamydia pneumoniae | rifampicin|rifalazil | Reslit | Candidate |
| S519Y | - | - | Chlamydia pneumoniae | rifampicin|rifalazil | Reslit | Candidate |
| S451L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D452N | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H447Y | - | - | - | rifamycins | Reslit | Candidate |
| A286V | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| I480V | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| E460D | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| P483L | - | multiple resistance variants | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| R552C | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| S485P | - | - | Clostridioides difficile | rifampicin | Reslit | Candidate |
| D531V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| F424L | - | - | Mycobacterium tuberculosis | rifampicin | ReslitResFinder Database | Candidate |
| T427A | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| T427T | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L430R | - | multiple resistance variants, single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| F433F | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L452Q | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q432H | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| Q432R | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| Q432Q | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| P439L | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitCard Database | Candidate | |
| S441S | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| T525N | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S482P | - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate |
| Q486L | - | - | Streptococcus pneumoniae, Staphylococcus aureus | rifampicin | Reslit | Candidate |
| D489V | - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate |
| H499L | - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate |
| H499Y | - | - | Streptococcus pneumoniae, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S509P | - | - | Rhodococcus equi | rifampicin | Reslit | Candidate |
| L530A | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L533A | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| N516A | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L456I | - | - | - | rifampicin | Reslit | Candidate |
| R484C | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | ReslitReference Gene Catalog | Candidate |
| R484H | - | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | ReslitResFinder DatabaseReference Gene Catalog | Candidate |
| R484S | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| S509R | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L461V | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| H437Y | - | - | Streptomyces coelicolor, Streptomyces griseus, Streptomyces antibioticus, Streptomyces parvulus, Streptomyces lavendulae, Amycolatopsis orientalis, Streptomyces erythraea | rifampicinstreptomycin|actinorhodin|erythromycin|formycin|vancomycin | Reslit | Candidate |
| T456I | - | resistance | Mycobacterium avium | rifabutin|rifampicin | Reslit | Candidate |
| R489H | - | - | Enterococcus faecalis | rifampicin | Reslit | Candidate |
| L104P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L104F | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L104V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S522W | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| V533P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H486N | - | - | Streptococcus mitis | rifampicin | Reslit | Candidate |
| A477T | - | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | ReslitResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate |
| I527L | - | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | ReslitResFinder DatabaseReference Gene Catalog | Candidate |
| S433L | - | - | Streptomyces coelicolor | rifampicin | Reslit | Candidate |
| L525P | - | Target modification, single resistance variant | Helicobacter pylori | rifampicin|rifabutinrifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| Q527K | - | single resistance variant | Helicobacter pylori | rifampicin|rifabutinrifampicin | ReslitCard Database | Candidate |
| D530V | - | single resistance variant | Helicobacter pylori | rifampicin|rifabutinrifampicin | ReslitCard Database | Candidate |
| D530N | - | single resistance variant | Helicobacter pylori | rifampicin|rifabutinrifampicin | ReslitCard Database | Candidate |
| H540N | - | Target modification, single resistance variant | Helicobacter pylori | rifampicin|rifabutinrifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| S545L | - | single resistance variant | Helicobacter pylori | rifampicin|rifabutinrifampicin | ReslitCard Database | Candidate |
| I586N | - | single resistance variant | Helicobacter pylori | rifampicin|rifabutinrifampicin | ReslitCard Database | Candidate |
| I586L | - | single resistance variant | Helicobacter pylori | rifampicin|rifabutinrifampicin | ReslitCard Database | Candidate |
| V149F | - | single resistance variant, multiple resistance variants | Helicobacter pylori | rifampicin|rifabutinrifampicin | ReslitCard Database | Candidate |
| R701H | - | single resistance variant | Helicobacter pylori | rifampicin|rifabutinrifampicin | ReslitCard Database | Candidate |
| S486L | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus, Staphylococcus pseudintermedius | rifampicinteicoplanin | ReslitResFinder DatabaseReference Gene Catalog | Candidate | |
| Q469K | - | single resistance variant | Staphylococcus epidermidis, Bacillus subtilis | rifampicin | ReslitCard Database | Candidate |
| Q469L | - | - | Staphylococcus epidermidis | rifampicin | Reslit | Candidate |
| Q469R | - | single resistance variant | Staphylococcus epidermidis, Bacillus subtilis | rifampicincefotaxime | ReslitCard Database | Candidate |
| H482D | - | - | Staphylococcus epidermidis | rifampicin | Reslit | Candidate |
| H482R | - | - | Staphylococcus epidermidis | rifampicin | Reslit | Candidate |
| H482Y | single resistance variant | Staphylococcus epidermidis, Bacillus subtilis | rifampicincefcefotaxime | ReslitCard Database | Candidate | |
| R485H | - | - | Staphylococcus epidermidis | rifampicin | Reslit | Candidate |
| S487F | - | - | Staphylococcus epidermidis | rifampicin | Reslit | Candidate |
| S487Y | - | - | Staphylococcus epidermidis | rifampicin | Reslit | Candidate |
| D472Y | - | Staphylococcus epidermidis, Bacillus subtilis | rifampicin | Reslit | Candidate | |
| S487C | - | - | Staphylococcus epidermidis | rifampicin | Reslit | Candidate |
| E461Q | - | - | Staphylococcus epidermidis | rifampicin | Reslit | Candidate |
| G1576C | - | - | Escherichia coli | rifampicin | Reslit | Candidate |
| S533L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| P513S | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D526N | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| G511S | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| G522S | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H513R | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| V251F | - | - | - | rifampicin | Reslit | Candidate |
| R637A | - | - | Mycobacterium smegmatis | rifampicin | Reslit | Candidate |
| H450Y | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H464Y | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H490Y | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S507L | - | DNA-directed RNA polymerase subunit beta RpoB | Mycobacterium tuberculosis, Clostridioides difficile | rifampicinrifaximin | ReslitReference Gene Catalog | Candidate |
| S508L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| M515V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S526L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| T508N | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S512N | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| N518H | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| P520P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| P520T | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L524L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R528H | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R529Q | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| T1037P | - | - | Escherichia coli | rifampicin | Reslit | Candidate |
| Q148L | DNA-directed RNA polymerase subunit beta RpoB | Escherichia coli, Shigella sonnei | rifampicin | ReslitReference Gene Catalog | Candidate | |
| I572S | - | - | Escherichia coli | rifampicin | Reslit | Candidate |
| I572N | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Escherichia coli, Shigella sonnei | rifampicinrifamycins | ReslitResFinder DatabaseReference Gene Catalog | Candidate | |
| R516H | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| 442-445del | - | - | Escherichia coli | ciprofloxacin | Reslit | Candidate |
| 455dup | - | - | Escherichia coli | ciprofloxacin | Reslit | Candidate |
| H481L | - | - | Staphylococcus aureus, Staphylococcus epidermidis | vancomycinrifampicin | Reslit | Candidate |
| R552L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S874Y | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| K891Q | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| P471R | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D542E | - | - | Neisseria meningitidis | rifampicin | Reslit | Candidate |
| H451G | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R454Q | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L464M | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| I750M | - | - | Clostridioides difficile | rifampicin | Reslit | Candidate |
| D1232E | - | Clostridioides difficile | rifampicin | Reslit | Candidate | |
| S450A | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitCard Database | Candidate |
| S450T | - | - | - | rifampicin | Reslit | Candidate |
| I170V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| K2068R | - | single resistance variant | Helicobacter pylori | rifampicin | ReslitCard Database | Candidate |
| I837V | - | single resistance variant | Helicobacter pylori | rifampicin | ReslitCard Database | Candidate |
| Q2079K | - | single resistance variant | Helicobacter pylori | rifampicin | ReslitCard Database | Candidate |
| E513K | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L492L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q490R | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| K1025E | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D574E | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R552H | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L525I | single resistance variant | Helicobacter pylori | rifampicinrifabutin | ReslitCard Database | Candidate | |
| S526T | - | - | Helicobacter pylori | rifampicin | Reslit | Candidate |
| Q527H | - | - | Helicobacter pylori | rifampicin | Reslit | Candidate |
| F528E | - | - | Helicobacter pylori | rifampicin | Reslit | Candidate |
| D530A | - | - | Helicobacter pylori | rifampicin | Reslit | Candidate |
| D530E | - | single resistance variant | Helicobacter pylori | rifampicin | ReslitCard Database | Candidate |
| D530G | - | single resistance variant | Helicobacter pylori | rifampicin | ReslitCard Database | Candidate |
| T539A | - | - | Helicobacter pylori | rifampicin | Reslit | Candidate |
| H540C | - | - | Helicobacter pylori | rifampicin | Reslit | Candidate |
| L547F | - | - | Helicobacter pylori | rifampicin | Reslit | Candidate |
| L511Q | - | DNA-directed RNA polymerase subunit beta RpoB | Mycobacterium tuberculosis, Shigella sonnei | rifampicin | ReslitReference Gene Catalog | Candidate |
| L533Q | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| G248D | - | - | Neisseria gonorrhoeae | ceftriaxone | Reslit | Candidate |
| H553N | DNA-directed RNA polymerase subunit beta RpoB | Neisseria gonorrhoeae, Neisseria meningitidis | ceftriaxonerifampicin | ReslitReference Gene Catalog | Candidate | |
| E1175D | - | - | Neisseria gonorrhoeae | ceftriaxone | Reslit | Candidate |
| S540R | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H513L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Y42D | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| G52A | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H87G | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L92S | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L441S | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L450P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L457P | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| S513L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R526W | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| T511A | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L516V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H531R | - | Mycobacterium tuberculosis, Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| L731P | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate | |
| - | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| - | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| - | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| - | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| - | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R548H | - | increased MIC for rifampin | Mycobacterium tuberculosis, Mycobacterium smegmatis | rifampicin | Reslit | Candidate |
| Y531N | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| E442H | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| L527F | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D516L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| A1075A | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| N413H | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R511C | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| E521D | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| F505V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| I572V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S388L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q409R | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H481D | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | ReslitResFinder DatabaseReference Gene Catalog | Candidate | |
| Q468R | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | ReslitResFinder DatabaseReference Gene Catalog | Candidate | |
| A411V | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| A425G | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| V424G | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| Q442H | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| L455P | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| S437Q | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| Q438Y | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| S492F | - | - | Flavobacterium psychrophilum | rifampicin | Reslit | Candidate |
| Q474R | - | - | Flavobacterium psychrophilum | rifampicin | Reslit | Candidate |
| D477Y | - | - | Flavobacterium psychrophilum | rifampicin | Reslit | Candidate |
| H516V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| G601V | - | - | - | rifampicin | Reslit | Candidate |
| P45L | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitCard Database | Candidate |
| N474K | - | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Mycobacterium tuberculosis, Staphylococcus aureus | rifampicin | ReslitResFinder DatabaseReference Gene Catalog | Candidate |
| H517N | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| N519H | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R529G | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L530F | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L531L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R533P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| I491V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H526A | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S518L | - | - | Pseudomonas aeruginosa, P. stutzeri, P. mendocina, P. putida, P. protegens, P. fluorescens | rifampicin | Reslit | Candidate |
| R521G | - | - | Pseudomonas aeruginosa, P. stutzeri, P. mendocina, P. putida, P. protegens, P. fluorescens | rifampicin | Reslit | Candidate |
| P531L | - | - | Pseudomonas aeruginosa, P. stutzeri, P. mendocina, P. putida, P. protegens, P. fluorescens | rifampicin | Reslit | Candidate |
| E531G | - | - | Pseudomonas aeruginosa, P. stutzeri, P. mendocina, P. putida, P. protegens, P. fluorescens | rifampicin | Reslit | Candidate |
| G469C | - | - | Geobacillus kaustophilus, Bacillus subtilis | rifampicin | Reslit | Candidate |
| Q429H | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| M434I | - | single resistance variant, multiple resistance variants | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| R827C | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| 1295-1303del | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| I837L | - | - | Helicobacter pylori | rifampicin | Reslit | Candidate |
| H481F | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| S443F | - | - | Rhodococcus equi | rifampicin | Reslit | Candidate |
| H487D | - | - | Lactobacillus rhamnosus | rifampicin | Reslit | Candidate |
| H451Y | - | Mycobacterium tuberculosis, Mycobacterium leprae | rifampicin | Reslit | Candidate | |
| Q438K | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q438E | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q438P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| T433I | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| Y737S | - | - | - | rifampicin | Reslit | Candidate |
| F737Y | - | - | Staphylococcus aureus | daptomycin | Reslit | Candidate |
| S442Y | The mutation causes a serine to tyrosine substitution at position 442, leading to a more hydrophobic environment in the rifampin binding pocket, which reduces the effectiveness of rifampin., DNA-directed RNA polymerase subunit beta RpoB | Corynebacterium diphtheriae, Streptomyces albus | rifampicinrifamycins | ReslitReference Gene Catalog | Candidate | |
| A477V | - | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicinbeta lactams|rifampicin | ReslitResFinder DatabaseReference Gene Catalog | Candidate |
| D550G | - | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | ReslitResFinder DatabaseReference Gene Catalog | Candidate |
| Q526D | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q526Y | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q526L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q526R | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q526V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S531Q | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| T508T | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| F514L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| M515T | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S222L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q513H | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| N518S | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S531T | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L533R | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| Y513D | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S516L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S516G | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| G516V | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| P526R | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| P526S | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Y516H | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R503H | - | - | Staphylococcus aureus | vancomycin | Reslit | Candidate |
| P519L | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| L488S | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| G489V | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| G442W | - | Staphylococcus aureus, Mycobacterium tuberculosis | rifampicin | ReslitResFinder Database | Candidate | |
| P471Q | - | Staphylococcus aureus | rifampicin | Reslit | Candidate | |
| I31F | - | - | Mycobacterium tuberculosis | pyrazinamide | Reslit | Candidate |
| R29S | - | - | Mycobacterium tuberculosis | pyrazinamide | Reslit | Candidate |
| H102P | - | - | Mycobacterium tuberculosis | ethionamide | Reslit | Candidate |
| H315N | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q856H | - | - | Streptomyces albulus | rifampicin | Reslit | Candidate |
| H1028R | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| N518D | - | - | Escherichia coli, Mycobacterium smegmatis, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S512F | - | Escherichia coli, Mycobacterium smegmatis, Salmonella enterica | rifampicin | Reslit | Candidate | |
| R529H | - | Escherichia coli, Mycobacterium smegmatis | rifampicin | Reslit | Candidate | |
| Q490P | - | - | Salmonella enterica | rifampicin | Reslit | Candidate |
| E523D | - | - | Salmonella enterica | rifampicin | Reslit | Candidate |
| S499F | - | - | Salmonella enterica | rifampicin | Reslit | Candidate |
| E142A | - | - | Salmonella enterica | rifampicin | Reslit | Candidate |
| G713C | - | - | Salmonella enterica | rifampicin | Reslit | Candidate |
| R436H | - | - | Staphylococcus aureus | dalbavancin|teicoplanin | Reslit | Candidate |
| I1491S | - | - | Mycobacterium bovis | rifampicin | Reslit | Candidate |
| L531F | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| V382I | - | - | Riemerella anatipestifer | rifampicin | Reslit | Candidate |
| H491N | - | Riemerella anatipestifer | rifampicin | Reslit | Candidate | |
| H491D | - | - | Riemerella anatipestifer | rifampicin | Reslit | Candidate |
| H491Y | - | - | Riemerella anatipestifer | rifampicin | Reslit | Candidate |
| H491R | - | - | Riemerella anatipestifer | rifampicin | Reslit | Candidate |
| R494K | - | - | Riemerella anatipestifer | rifampicin | Reslit | Candidate |
| G502K | - | - | Riemerella anatipestifer | rifampicin | Reslit | Candidate |
| S539Y | - | - | Riemerella anatipestifer | rifampicin | Reslit | Candidate |
| S539F | - | - | Riemerella anatipestifer | rifampicin | Reslit | Candidate |
| S435L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S445L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| G767S | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| V136F | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| H471K | - | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate |
| D523E | - | - | Mycobacterium abscessus | rifampicin|rifabutin | Reslit | Candidate |
| V1032I | - | - | Staphylococcus pseudintermedius | vancomycin | Reslit | Candidate |
| L3225P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D483G | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| T480K | - | - | Staphylococcus aureus | oxacillin | Reslit | Candidate |
| T622I | - | - | Staphylococcus aureus | oxacillin | Reslit | Candidate |
| S485L | - | - | Escherichia coli, Salmonella enterica | rifampicin | Reslit | Candidate |
| I65T | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H451L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D551E | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| P473L | - | - | Mycobacterium abscessus | rifamycins | Reslit | Candidate |
| F506L | - | - | Mycobacterium intracellulare | rifampicin | Reslit | Candidate |
| E509H | - | - | Mycobacterium yongonense | rifampicin | Reslit | Candidate |
| R406H | - | - | - | vancomycin | Reslit | Candidate |
| S446P | - | - | Cutibacterium avidum | rifampicin | Reslit | Candidate |
| S522Q | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H442R | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| D432G | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S438L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L449P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| G450D | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| V167M | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q432E | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate | |
| K446Q | single resistance variant, multiple resistance variants | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate | |
| M434T | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| S428R | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| D435A | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| L521Y | - | enhances rifampicin binding | Escherichia coli | rifampicin | Reslit | Candidate |
| T525D | - | enhances rifampicin binding | Escherichia coli | rifampicin | Reslit | Candidate |
| T508I | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S468P | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| Q486R | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| H481R | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| E568K | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| R197L | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| D675A | - | restored ampicillin MIC and reduced persistence | Escherichia coli | ampicillin | Reslit | Candidate |
| N438K | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| T444A | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S428I | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| S662A | - | - | Salmonella enterica | ciprofloxacin|meropenem | Reslit | Candidate |
| D776N | - | - | - | bedaquiline | Reslit | Candidate |
| K579R | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| H437R | - | - | Streptomyces coelicolor, Streptomyces griseus, Streptomyces antibioticus, Streptomyces parvulus, Streptomyces lavendulae, Amycolatopsis orientalis, Streptomyces erythraea | streptomycin|actinorhodin|erythromycin|formycin|vancomycin | Reslit | Candidate |
| Q424K | - | - | Streptomyces coelicolor, Streptomyces griseus, Streptomyces antibioticus, Streptomyces parvulus, Streptomyces lavendulae, Amycolatopsis orientalis, Streptomyces erythraea | streptomycin | Reslit | Candidate |
| N967I | - | confers high-dose methicillin tolerance and promotes heterogeneous-to-homogeneous conversion of β-lactam resistance, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | methicillinbeta lactams | ReslitReference Gene Catalog | Candidate |
| E123K | - | - | - | rifampicin | Reslit | Candidate |
| T481A | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R451S | - | - | - | rifampicin | Reslit | Candidate |
| G537C | - | - | - | rifampicin | Reslit | Candidate |
| G534S | - | - | - | rifampicin | Reslit | Candidate |
| L571Q | - | - | - | rifampicin | Reslit | Candidate |
| Q148P | - | - | rifampicin | Reslit | Candidate | |
| S531P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S572T | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S572G | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| F572I | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S315T | - | - | - | isoniazid | Reslit | Candidate |
| S315G | - | - | - | isoniazid | Reslit | Candidate |
| D94G | - | - | - | fluoroquinolones | Reslit | Candidate |
| D94Y | - | - | - | fluoroquinolones | Reslit | Candidate |
| D94N | - | - | - | fluoroquinolones | Reslit | Candidate |
| Q137R | - | - | Bacillus subtilis | rifampicin | Reslit | Candidate |
| L489S | - | - | Bacillus subtilis | rifampicin | Reslit | Candidate |
| S437L | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| H476R | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| L533E | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| E588G | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| E392D | - | - | Brucella melitensis | rifampicin | Reslit | Candidate |
| H445T | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitCard Database | Candidate |
| Q438H | - | - | Mycobacterium leprae | rifampicin | Reslit | Candidate |
| V490L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q424L | - | - | Streptomyces diastatochromogenes | rifampicin | Reslit | Candidate |
| D427V | - | - | Streptomyces diastatochromogenes | rifampicin | Reslit | Candidate |
| R917C | - | - | Staphylococcus aureus | vancomycin | Reslit | Candidate |
| V496A | - | - | - | rifampicin | Reslit | Candidate |
| K43T | - | - | Escherichia coli | rifampicin | Reslit | Candidate |
| E18K | - | - | - | rifampicin | Reslit | Candidate |
| S444F | - | Corynebacterium urealyticum, Corynebacterium diphtheriae | rifampicin | Reslit | Candidate | |
| Q511K | - | - | Corynebacterium urealyticum | rifampicin | Reslit | Candidate |
| S444N | - | - | Corynebacterium urealyticum | rifampicin | Reslit | Candidate |
| D441A | - | loss of interactions with drug except Gly438, Phe439 and Arg465 | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L530P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| Q517Q | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R130C | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| N1012S | - | - | Staphylococcus aureus | vancomycin | Reslit | Candidate |
| D172G | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H175C | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| I191L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L177F | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| R431G | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| K460Q | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| I668F | - | - | - | fluoroquinolones | Reslit | Candidate |
| F668S | - | - | - | fluoroquinolones | Reslit | Candidate |
| F668V | - | - | - | fluoroquinolones | Reslit | Candidate |
| F668L | - | - | - | fluoroquinolones | Reslit | Candidate |
| P475S | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| T518S | - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate |
| D435N | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitResFinder DatabaseCard Database | Candidate |
| M434V | - | single resistance variant, multiple resistance variants | Mycobacterium tuberculosis | rifampicin | ReslitCard Database | Candidate |
| R448L | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitCard Database | Candidate |
| K274Q | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| L494P | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| P454L | - | - | Mycobacterium tuberculosis | rifampicin | ReslitResFinder Database | Candidate |
| I491L | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H432Y | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| H435Y | - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate |
| S441A | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitCard Database | Candidate |
| H929P | - | dysregulation of RNAP transcription activity | Staphylococcus aureus | oxacillin|cefoxitin|imipenem | Reslit | Candidate |
| L443F | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ReslitCard Database | Candidate |
| Q409H | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| E423A | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| F424S | - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate |
| G426S | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| G426D | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| T427S | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| T427P | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| T427H | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| S428Q | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| S428T | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| Q429K | - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate |
| L430V | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| S431R | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| S431G | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard DatabaseReslit | Candidate | |
| S431I | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| Q432N | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| Q432* | - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate |
| F433L | - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate |
| F433V | - | multiple resistance variants | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| Q436L | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| Q436H | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| N437Y | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| N437H | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| N437I | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| N437T | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| L440M | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| L440L | - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate |
| L440P | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| S441W | single resistance variant | Mycobacterium tuberculosis, Mycobacterium smegmatis | rifampicincapreomycin | ResFinder DatabaseCard DatabaseReslit | Candidate | |
| G442A | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| L443S | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| L443W | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| T444P | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| T444I | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| K446N | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| R447P | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| R447H | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| S450Q | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| P454S | - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate |
| P454H | multiple resistance variants | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard DatabaseReslit | Candidate | |
| P454R | - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate |
| E460G | - | multiple resistance variants | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| S472A | - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate |
| I480T | - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate |
| E481G | - | multiple resistance variants | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| T482P | - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate |
| L490V | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| E592D | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | ResFinder DatabaseCard Database | Candidate |
| S463P | - | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | ResFinder DatabaseReference Gene Catalog | Candidate |
| Q465K | - | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | ResFinder DatabaseReference Gene Catalog | Candidate |
| Q465R | - | Target modification, single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | ResFinder DatabaseCard DatabaseReference Gene Catalog | Candidate |
| M470T | - | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | ResFinder DatabaseReference Gene Catalog | Candidate |
| I527F | - | Target modification, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | ResFinder DatabaseReference Gene Catalog | Candidate |
| ins475G | - | Target modification | Staphylococcus aureus | rifampicin | ResFinder Database | Candidate |
| ins475H | - | Target modification | Staphylococcus aureus | rifampicin | ResFinder Database | Candidate |
| A478N | - | single resistance variant | Bacillus subtilis | rifampicin | Card Database | Candidate |
| L487F | - | multiple resistance variants | Clostridium ljungdahlii | rifampicin | Card Database | Candidate |
| H502L | - | single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Clostridium ljungdahlii, Clostridioides difficile | rifampicinrifaximin | Card DatabaseReference Gene Catalog | Candidate |
| Q1073R | - | single resistance variant | Clostridium ljungdahlii | rifampicin | Card Database | Candidate |
| S498T | - | single resistance variant | Clostridium ljungdahlii | rifampicin | Card Database | Candidate |
| S488P | - | single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Clostridium ljungdahlii, Clostridioides difficile | rifampicinrifamycins | Card DatabaseReference Gene Catalog | Candidate |
| S550Y | - | single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Clostridium ljungdahlii, Clostridioides difficile | rifampicinrifaximin | Card DatabaseReference Gene Catalog | Candidate |
| S550F | - | single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Clostridium ljungdahlii, Clostridioides difficile | rifampicinrifaximin | Card DatabaseReference Gene Catalog | Candidate |
| D492N | - | single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Clostridium ljungdahlii, Clostridioides difficile | rifampicinrifaximin | Card DatabaseReference Gene Catalog | Candidate |
| S531fs | - | frameshift mutation | Escherichia coli | rifampicin | Card Database | Candidate |
| V149E | - | single resistance variant | Helicobacter pylori | rifampicin | Card Database | Candidate |
| D530Y | - | single resistance variant | Helicobacter pylori | rifampicin | Card Database | Candidate |
| D530I | - | single resistance variant | Helicobacter pylori | rifampicin | Card Database | Candidate |
| D530L | - | single resistance variant | Helicobacter pylori | rifampicin | Card Database | Candidate |
| D530F | - | single resistance variant | Helicobacter pylori | rifampicin | Card Database | Candidate |
| A2414V | - | single resistance variant | Helicobacter pylori | rifampicin | Card Database | Candidate |
| A2414T | - | single resistance variant | Helicobacter pylori | rifampicin | Card Database | Candidate |
| V149W | - | single resistance variant | Helicobacter pylori | rifampicin | Card Database | Candidate |
| V149D | - | single resistance variant | Helicobacter pylori | rifampicin | Card Database | Candidate |
| V149K | - | single resistance variant | Helicobacter pylori | rifampicin | Card Database | Candidate |
| V149Q | - | single resistance variant | Helicobacter pylori | rifampicin | Card Database | Candidate |
| F2538L | - | single resistance variant | Helicobacter pylori | rifampicin | Card Database | Candidate |
| T2537A | - | single resistance variant | Helicobacter pylori | rifampicin | Card Database | Candidate |
| V2592L | - | single resistance variant | Helicobacter pylori | rifampicin | Card Database | Candidate |
| I2619V | - | single resistance variant | Helicobacter pylori | rifampicin | Card Database | Candidate |
| V148I | - | multiple resistance variants | Helicobacter pylori | rifampicin | Card Database | Candidate |
| V472I | - | single resistance variant | Mycobacterium leprae | rifampicin | Card Database | Candidate |
| A451G | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| D435L | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| Q436R | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| Q436P | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| N437S | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| N438H | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| P439S | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| P439A | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| S441V | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| S441M | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| S441K | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| G442E | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| D545E | single resistance variant | Mycobacterium tuberculosis | rifampicinrifampicin|rifabutin | Card DatabaseReslit | Candidate | |
| T444S | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| G981D | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| T676P | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| V359A | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| K446R | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| K446E | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| K446T | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card DatabaseReslit | Candidate | |
| R448K | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| R448Q | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| S450G | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| S450V | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| S450M | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| S450C | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| L452V | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| L452M | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| F425Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| G426Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| T427Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| S428Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| Q429Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| L430Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| S431Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| Q432Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| F433Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| M434Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| D435Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| Q436Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| N437Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| N438Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| P439Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| L440Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| S441Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| G442Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| L443Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| T444Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| H445Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| K446Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| R447Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| R448Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| L449Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| S450Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| A451Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| Q432Ter | - | nonsense mutation | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| L452Var | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| T427N | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| S431N | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| P439T | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| T427G | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| F503S | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| G836S | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| H835R | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| P45S | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| Q975H | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| R827H | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| T427I | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| S428G | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| D435T | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| L457R | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| L452R | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| Q429L | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| Q429P | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| D435K | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| L430M | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| S441Ter | - | nonsense mutation | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| S540A | - | multiple resistance variants | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| Q432D | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| H445E | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| M434L | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| M434R | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| Q436N | - | single resistance variant | Mycobacterium tuberculosis | rifampicin | Card Database | Candidate |
| A1085V | - | single resistance variant, DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | daptomycin | Card DatabaseReference Gene Catalog | Candidate |
| S583L | - | DNA-directed RNA polymerase subunit beta RpoB | Acinetobacter baumannii | rifampicin | Reference Gene Catalog | Candidate |
| S488Y | - | DNA-directed RNA polymerase subunit beta RpoB | Clostridioides difficile | rifaximin | Reference Gene Catalog | Candidate |
| Q489L | - | DNA-directed RNA polymerase subunit beta RpoB | Clostridioides difficile | rifaximin | Reference Gene Catalog | Candidate |
| D492Y | - | DNA-directed RNA polymerase subunit beta RpoB | Clostridioides difficile | rifaximin | Reference Gene Catalog | Candidate |
| R505L | - | DNA-directed RNA polymerase subunit beta RpoB | Clostridioides difficile | rifaximin | Reference Gene Catalog | Candidate |
| G510R | - | DNA-directed RNA polymerase subunit beta RpoB | Clostridioides difficile | rifaximin | Reference Gene Catalog | Candidate |
| L584F | - | DNA-directed RNA polymerase subunit beta RpoB | Clostridioides difficile | rifaximin | Reference Gene Catalog | Candidate |
| Q1074K | - | DNA-directed RNA polymerase subunit beta RpoB | Clostridioides difficile | fidaxomicin | Reference Gene Catalog | Candidate |
| Q1074R | - | DNA-directed RNA polymerase subunit beta RpoB | Clostridioides difficile | fidaxomicin | Reference Gene Catalog | Candidate |
| V1143D | - | DNA-directed RNA polymerase subunit beta RpoB | Clostridioides difficile | fidaxomicin | Reference Gene Catalog | Candidate |
| V1143F | - | DNA-directed RNA polymerase subunit beta RpoB | Clostridioides difficile | fidaxomicin | Reference Gene Catalog | Candidate |
| V1143G | - | DNA-directed RNA polymerase subunit beta RpoB | Clostridioides difficile | fidaxomicin | Reference Gene Catalog | Candidate |
| V1143L | - | DNA-directed RNA polymerase subunit beta RpoB | Clostridioides difficile | fidaxomicin | Reference Gene Catalog | Candidate |
| S442F | DNA-directed RNA polymerase subunit beta RpoB | Corynebacterium diphtheriae, Streptomyces albus | rifamycinsrifampicin | Reference Gene CatalogReslit | Candidate | |
| S442N | - | DNA-directed RNA polymerase subunit beta RpoB | Corynebacterium diphtheriae | rifamycins | Reference Gene Catalog | Candidate |
| Q517QDQ | - | DNA-directed RNA polymerase subunit beta RpoB | Shigella sonnei | rifampicin | Reference Gene Catalog | Candidate |
| A1131T | - | DNA-directed RNA polymerase subunit beta RpoB | Haemophilus influenzae | rifampicin | Reference Gene Catalog | Candidate |
| P157L | - | DNA-directed RNA polymerase subunit beta RpoB | Neisseria gonorrhoeae | cephalosporins | Reference Gene Catalog | Candidate |
| G158V | - | DNA-directed RNA polymerase subunit beta RpoB | Neisseria gonorrhoeae | cephalosporins | Reference Gene Catalog | Candidate |
| L560S | - | DNA-directed RNA polymerase subunit beta RpoB | Neisseria gonorrhoeae | rifampicin | Reference Gene Catalog | Candidate |
| D543E | - | DNA-directed RNA polymerase subunit beta RpoB | Neisseria meningitidis | rifampicin | Reference Gene Catalog | Candidate |
| D543G | - | DNA-directed RNA polymerase subunit beta RpoB | Neisseria meningitidis | rifampicin | Reference Gene Catalog | Candidate |
| D543N | - | DNA-directed RNA polymerase subunit beta RpoB | Neisseria meningitidis | rifampicin | Reference Gene Catalog | Candidate |
| D543V | - | DNA-directed RNA polymerase subunit beta RpoB | Neisseria meningitidis | rifampicin | Reference Gene Catalog | Candidate |
| S549F | - | DNA-directed RNA polymerase subunit beta RpoB | Neisseria meningitidis | rifampicin | Reference Gene Catalog | Candidate |
| H553L | - | DNA-directed RNA polymerase subunit beta RpoB | Neisseria meningitidis | rifampicin | Reference Gene Catalog | Candidate |
| H553R | - | DNA-directed RNA polymerase subunit beta RpoB | Neisseria meningitidis | rifampicin | Reference Gene Catalog | Candidate |
| S558F | - | DNA-directed RNA polymerase subunit beta RpoB | Neisseria meningitidis | rifampicin | Reference Gene Catalog | Candidate |
| G561S | - | DNA-directed RNA polymerase subunit beta RpoB | Neisseria meningitidis | rifampicin | Reference Gene Catalog | Candidate |
| S463N | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | Reference Gene Catalog | Candidate |
| Q468I | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | Reference Gene Catalog | Candidate |
| N474KG | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | Reference Gene Catalog | Candidate |
| N474L | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | Reference Gene Catalog | Candidate |
| N474NH | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | Reference Gene Catalog | Candidate |
| A477G | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | rifampicin | Reference Gene Catalog | Candidate |
| G639C | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | beta lactams | Reference Gene Catalog | Candidate |
| Q643P | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | beta lactams | Reference Gene Catalog | Candidate |
| R644H | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | beta lactams | Reference Gene Catalog | Candidate |
| H929Q | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | beta lactams | Reference Gene Catalog | Candidate |
| D949H | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | beta lactams | Reference Gene Catalog | Candidate |
| G1139D | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus aureus | beta lactams | Reference Gene Catalog | Candidate |
| A473AA | - | DNA-directed RNA polymerase subunit beta RpoB | Staphylococcus pseudintermedius | rifampicin | Reference Gene Catalog | Candidate |
| - | - | Mycobacterium tuberculosis | ethionamide | Reslit | Candidate | |
| - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate | |
| - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate | |
| S341L | - | Chlamydia trachomatis | rifampicin | Reslit | Candidate | |
| H415R | - | - | rifampicin | Reslit | Candidate | |
| - | - | - | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| D450V | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Staphylococcus aureus | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | amikacin|kanamycin|capreomycin | Reslit | Candidate | |
| - | - | - | rifampicin | Reslit | Candidate | |
| H472R | - | Mycobacterium tuberculosis, Mycobacterium leprae, Mycobacterium kansasii | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| H521R | - | Pseudomonas aeruginosa, P. fulva, P. stutzeri, P. mendocina, P. protegens, P. fluorescens, P. putida | rifampicin | Reslit | Candidate | |
| I527P | - | Staphylococcus aureus | rifampicin | Reslit | Candidate | |
| I528V | - | Bacillus subtilis | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| Y531C | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | - | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| L172R | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| L172F | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Staphylococcus aureus | methicillin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Escherichia coli, Salmonella enterica | rifampicin | Reslit | Candidate | |
| - | - | Acinetobacter baumannii | rifampicin | Reslit | Candidate | |
| P353L | - | Listeria monocytogenes | rifampicin | Reslit | Candidate | |
| H442Y | - | - | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| R456L | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium leprae | capreomycin | Reslit | Candidate | |
| N481Y | - | Staphylococcus aureus | rifampicin | Reslit | Candidate | |
| H482N | - | Bacillus subtilis | rifampicin | Reslit | Candidate | |
| - | - | - | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | - | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| Q150R | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| S175F | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis, Mycobacterium kansasii, Mycobacterium africanum | rifampicinrifampicin|rifabutin | Reslit | Candidate | |
| P177S | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| Q513Q | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| Q531P | - | - | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Neisseria meningitidis | rifampicin | Reslit | Candidate | |
| Q510V | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| P564R | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| L524fs | - | - | rifampicin | Reslit | Candidate | |
| L378R | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | - | rifampicin | Reslit | Candidate | |
| A478D | - | Bacillus subtilis | rifampicin | Reslit | Candidate | |
| - | - | - | rifampicin | Reslit | Candidate | |
| - | - | - | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| D521N | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Bartonella krasnovii | rifampicin | Reslit | Candidate | |
| V538I | - | Helicobacter pylori | rifabutin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | confers resistance to rifampin | Rickettsia prowazekii | rifampicin | Reslit | Candidate | |
| I70M | - | Mycobacterium smegmatis, Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| V857E | - | - | fluoroquinolones | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| E207K | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| V262A | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| V408G | - | Escherichia coli | rifampicin | Reslit | Candidate | |
| Y421H | - | - | rifampicin | Reslit | Candidate | |
| F492L | - | - | fluoroquinolones | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| S582A | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| D1160E | - | Clostridioides difficile | rifampicin | Reslit | Candidate | |
| - | - | Pseudomonas aeruginosa | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin|rifabutin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Streptococcus pneumoniae | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| Y178H | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| S493R | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| S455L | - | Acinetobacter baylyi | rifampicin | Reslit | Candidate | |
| S455F | - | Acinetobacter baylyi | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| S532N | - | - | rifampicin | Reslit | Candidate | |
| F514F | - | Mycobacterium tuberculosis | rifampicin | Reslit | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | - | Mycobacterium tuberculosis | rifampicin | ResFinder Database | Candidate | |
| - | Target modification | Staphylococcus aureus | rifampicin | ResFinder Database | Candidate | |
| - | Target modification | Staphylococcus aureus | rifampicin | ResFinder Database | Candidate | |
| - | Target modification | Staphylococcus aureus | rifampicin | ResFinder Database | Candidate | |
| - | Target modification | Staphylococcus aureus | rifampicin | ResFinder Database | Candidate | |
| - | Target modification | Staphylococcus aureus | rifampicin | ResFinder Database | Candidate | |
| - | Target modification | Staphylococcus aureus | rifampicin | ResFinder Database | Candidate |
Isolation of Rifampin-Resistant Mutants of Listeria monocytogenes and Their Characterization by rpoB Gene Sequencing, Temperature Sensitivity for Growth, and Interaction with an Epithelial Cell Line.
Evaluation of the invader assay, a linear signal amplification method, for identification of mutations associated with resistance to rifampin and isoniazid in Mycobacterium tuberculosis.
Compensatory evolution in rifampin-resistant Escherichia coli.
The study focuses on compensatory evolution in rifampin-resistant E. coli, highlighting mutations in the rpoB gene.
rpoB
Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates.
Detected in one isolate and 5 of 18 RIF-resistant strains with no cluster I mutation
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Genetic diversity and evidence for acquired antimicrobial resistance in Mycobacterium tuberculosis at a large hospital in South India.
Molecular basis of rifampin and isoniazid resistance in Mycobacterium bovis strains isolated in Sardinia, Italy.
Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Biological cost of rifampin resistance from the perspective of Staphylococcus aureus.
Mutations in rpoB confer rifampin resistance
rpoB
Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice.
Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate.
Mutations in rpoB gene associated with rifampin resistance
Multiple rpoB mutants of Mycobacterium tuberculosis and second-order selection.
Mutations in rpoB are associated with rifampin resistance in M. tuberculosis.
Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazil.
Cross-resistance of Escherichia coli RNA polymerases conferring rifampin resistance to different antibiotics.
Mutations in the rpoB gene encoding the beta subunit of RNA polymerase confer resistance to rifampin and related antibiotics.
Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis.
all mutations are in the rpoB gene and confer resistance to rifampin
Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency.
Mutations in the rpoB gene were identified through sequencing of gene fragments.
Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence.
Mutations in the rpoB gene were identified as conferring rifampin resistance in Staphylococcus aureus.
Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology.
Mutations in the rpoB gene are associated with rifampin resistance
Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy.
The mutation was not associated with the RIF resistance phenotype.
Interstrain gene transfer in Chlamydia trachomatis in vitro: mechanism and significance.
In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus.
Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile.
Mutations in rpoB are associated with rifampin and rifaximin resistance in C. difficile
Clostridioides difficile rpoB with mutation conferring resistance to rifampicin; CARD accession: CARD:3004563
High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital.
All rifampin-resistant isolates contained the R505K substitution
Clostridioides difficile rpoB with mutation conferring resistance to rifampicin; CARD accession: CARD:3004563
rpoB
Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin.
Some mutations in the rpoB gene can reveal drug-resistant phenotype only in a specific genetic background of the host.
Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa.
Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.
Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam.
Drug resistant Mycobacterium tuberculosis of the Beijing genotype does not spread in Sweden.
associated with multidrug resistance
Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing.
Mutations in rpoB are associated with rifampin resistance in N. meningitidis.
rpoB
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
Previously reported
Rapid Detection of Multidrug-Resistant Mycobacterium tuberculosis by Use of Real-Time PCR and High-Resolution Melt Analysis.
Rapid pneumococcal evolution in response to clinical interventions.
Genetic variation of Mycobacterium tuberculosis circulating in Kharkiv Oblast, Ukraine.
Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in South-Western Uganda.
Three isolates had this mutation.
Dynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatment.
The GAC516GTC mutation in rpoB is responsible for rifampicin resistance.
Clonal population of Mycobacterium tuberculosis strains reside within multiple lung cavities.
The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
International spread of MDR TB from Tugela Ferry, South Africa.
rpoB mutation associated with rifampin resistance
Comprehensive multicenter evaluation of a new line probe assay kit for identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis.
The I572F mutation was associated with rifampin resistance.
Rapid detection of rpoB mutations in rifampin resistant M. tuberculosis from sputum samples by denaturing gradient gel electrophoresis.
mutations in rpoB gene associated with rifampin resistance
Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China.
Includes several novel mutations
Genetic determinants of drug-resistant tuberculosis among HIV-infected patients in Nigeria.
Molecular detection and drug resistance of Mycobacterium tuberculosis complex from cattle at a dairy farm in the Nkonkobe region of South Africa: a pilot study.
Drug-resistant tuberculosis transmission and resistance amplification within families.
In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy.
The patient developed resistance to rifaximin, leading to the emergence of resistant C. difficile isolates.
Clostridioides difficile rpoB with mutation conferring resistance to rifampicin; CARD accession: CARD:3004563
rpoB
Characterization of Rif R Mutants of Photorhabdus luminescens LN2 and Their Effects on Nematicidal Activity
Mutations in rpoB gene were responsible for Rif-resistance and loss of nematicidal activity.
Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.
Dominant incidence of multidrug and extensively drug-resistant specific Mycobacterium tuberculosis clones in Osaka Prefecture, Japan.
Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis.
Mutations in the rpoB gene are responsible for rifampin resistance.
Primary multidrug-resistant leprosy, United States.
First Evaluation of GenoType MTBDRplus 2.0 Performed Directly on Respiratory Specimens in Central America.
Evaluation of MTBDRplus and MTBDRsl in Detecting Drug-Resistant Tuberculosis in a Chinese Population.
Coinfection and Emergence of Rifamycin Resistance during a Recurrent Clostridium difficile Infection.
Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
Multiple mutations in rpoB were associated with RIF resistance
Novel rapid PCR for the detection of Ile491Phe rpoB mutation of Mycobacterium tuberculosis, a rifampicin-resistance-conferring mutation undetected by commercial assays.
Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages.
Evaluation of rifampicin resistance and 81-bp rifampicin resistant determinant region of rpoB gene mutations of Mycobacterium tuberculosis detected with XpertMTB/Rif in Cross River State, Nigeria.
Mutations in the rpoB gene were identified as the primary cause of rifampicin resistance in Mycobacterium tuberculosis.
Molecular drug susceptibility testing against the first-line (rifampin and isoniazid) and second-line (ciprofloxacin-amikacin and kanamycin) treatment in different subtypes of Mycobacterium simiae.
Antimicrobial Resistance Mechanisms in Mycobacterium tuberculosis: Role of Efflux Pumps and Mutations
Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.
Frequency of multi-drug resistance and mutations in Mycobacterium tuberculosis isolates from Punjab state of India.
Commonest known mutation for RIF resistance
Sequence analysis of the rifampicin resistance determining region (RRDR) of rpoB gene in multidrug resistance confirmed and newly diagnosed tuberculosis patients of Punjab, Pakistan.
mutations in rpoB gene associated with rifampicin resistance
Emergence and clonal transmission of multi-drug-resistant tuberculosis among patients in Chad.
Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates.
Mutations in rpoB gene are associated with rifabutin resistance
Comparative Genomic Analysis of Two Clonally Related Multidrug Resistant Mycobacterium tuberculosis by Single Molecule Real Time Sequencing.
The Versatile Mutational Resistome of Pseudomonas aeruginosa.
RNA polymerase mutations cause cephalosporin resistance in clinical Neisseria gonorrhoeae isolates.
The rpoB R201H mutation was identified in CRO RS isolates and confirmed to confer resistance through transformation experiments.
rpoB
Genetic Identification and Drug-Resistance Characterization of Mycobacterium tuberculosis Using a Portable Sequencing Device. A Pilot Study.
Mutation in rpoB gene associated with rifampicin resistance.
Genomic and Long-Term Transcriptomic Imprints Related to the Daptomycin Mechanism of Action Occurring in Daptomycin- and Methicillin-Resistant Staphylococcus aureus Under Daptomycin Exposure.
Mutations in rpoB gene leading to increased dlt operon expression and positive cell surface charge
Identification and characterization of mutations responsible for the β-lactam resistance in oxacillin-susceptible mecA-positive Staphylococcus aureus.
Identification of a novel tedizolid resistance mutation in rpoB of MRSA after in vitro serial passage.
The rpoB mutation was associated with resistance to multiple antimicrobials.
Prediction of rifampicin resistance beyond the RRDR using structure-based machine learning approaches.
The mutation I491F was identified as a low confidence mutation in the Miotto et al. study, showing weak clinical resistance evidence.
Rifampin, Rifapentine, and Rifabutin Are Active against Intracellular Periprosthetic Joint Infection-Associated Staphylococcus epidermidis.
The rpoB gene mutations were identified in rifampin-resistant isolates.
Analysis of drug resistance and mutation profiles in Mycobacterium tuberculosis isolates in a surveillance site in Beijing, China.
Drug Resistance Conferring Mutation and Genetic Diversity of Mycobacterium tuberculosis Isolates in Tuberculosis Lymphadenitis Patients; Ethiopia.
Tale of compounding oddities.
The S512T mutation in the rpoB gene was identified as a high-confidence mutation conferring rifampicin resistance.
A platform for detecting cross-resistance in antibacterial drug discovery.
Compensatory effects of M. tuberculosis rpoB mutations outside the rifampicin resistance-determining region.
Mutations P45L, P45S, I480V, V534M, and R827L are compensatory mutations that improve the fitness of the S450L mutant.
The DnaK Chaperone System Buffers the Fitness Cost of Antibiotic Resistance Mutations in Mycobacteria.
Mutations in rpoB confer rifampin resistance and require DnaK system for fitness.
DNA Breaks-Mediated Fitness Cost Reveals RNase HI as a New Target for Selectively Eliminating Antibiotic-Resistant Bacteria.
Rif R mutation
Microevolution of Mycobacterium tuberculosis Subpopulations and Heteroresistance in a Patient Receiving 27 Years of Tuberculosis Treatment in Germany.
Computational modeling and bioinformatic analyses of functional mutations in drug target genes in Mycobacterium tuberculosis.
Dependence of Xpert MTB/RIF Accuracy for Detecting Rifampin Resistance in Bronchoalveolar Lavage Fluid on Bacterial Load: A Retrospective Study in Beijing, China.
Mutations identified in rpoB gene associated with rifampicin resistance.
Antimicrobial Resistance Spectrum Conferred by pRErm46 of Emerging Macrolide (Multidrug)-Resistant Rhodococcus equi.
Mutations in rpoB confer resistance to rifampin.
Investigation of the Rv3065, Rv2942, Rv1258c, Rv1410c, and Rv2459 efflux pump genes expression among multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Early detection of MDR Mycobacterium tuberculosis mutations in Pakistan.
Mutations in rpoB are associated with Rifampicin resistance.
Comparative proteomic investigation of multiple methicillin-resistant Staphylococcus aureus strains generated through adaptive laboratory evolution.
Mutations in rpoB confer resistance to rifampin.
Antimicrobial Resistance in Chlamydia trachomatis: Mechanisms and Mutations
Mutations in rpoB are associated with rifampin resistance in C. trachomatis.
Transmission of multidrug-resistant tuberculosis in Shimen community in Shanghai, China: a molecular epidemiology study.
Practical approach to detection and surveillance of emerging highly resistant Mycobacterium tuberculosis Beijing 1071-32-cluster.
Mutation in rpoB
Molecular Characteristics of Rifampin-Sensitive and -Resistant Isolates and Characteristics of rpoB Gene Mutations in Methicillin-Resistant Staphylococcus aureus.
mutations in rpoB gene associated with rifampin resistance
The whole-genome sequencing in predicting Mycobacterium tuberculosis drug susceptibility and resistance in Papua, Indonesia.
A Survey of Spontaneous Antibiotic-Resistant Mutants of the Halophilic, Thermophilic Bacterium Rhodothermus marinus.
Mutations in rpoB gene
Whole-genome sequencing of Mycobacterium tuberculosis for prediction of drug resistance.
Multiple mutations in rpoB were associated with rifampicin resistance.
The Regulation of ManLAM-Related Gene Expression in Mycobacterium tuberculosis with Different Drug Resistance Profiles Following Isoniazid Treatment.
Drug-Resistant Characteristics, Genetic Diversity, and Transmission Dynamics of Rifampicin-Resistant Mycobacterium tuberculosis in Hunan, China, Revealed by Whole-Genome Sequencing.
Snapshot of Mycobacterium tuberculosis Phylogenetics from an Indian State of Arunachal Pradesh Bordering China.
Rapid Decline of Ceftazidime Resistance in Antibiotic-Free and Sublethal Environments Is Contingent on Genetic Background.
original mutation in MDR6-CAZ
Molecular Epidemiology of Mycobacterium tuberculosis Complex Strains in Urban and Slum Settings of Nairobi, Kenya.
Molecular mechanism of antibiotic resistance induced by mono- and twin-chained quaternary ammonium compounds.
Antimicrobial Resistance in Mycobacterium tuberculosis Clinical Isolates from HIV-Positive and HIV-Negative Patients in Russia
Transmission of multidrug-resistant tuberculosis in Jiangxi, China, and associated risk factors.
Multidrug-resistant tuberculosis clusters and transmission in Taiwan: a population-based cohort study.
This mutation is associated with rifampicin resistance.
A novel dual probe-based method for mutation detection using isothermal amplification.
Mutations at codons 516, 526, and 531 of rpo B were analyzed.
Meningococcal C Disease Outbreak Caused by Multidrug-Resistant Neisseria meningitidis, Fiji.
Only 1 strain contained the rpoB point mutation H553Y.
Potential of nanopore sequencing for tuberculosis diagnosis and drug resistance detection.
Phenotypic drug resistance and genetic mutations linked to resistance among extrapulmonary tuberculosis patients in Ethiopia: Insights from Whole Genome Sequencing.
This mutation is a group-2 WHO confidence grade mutation associated with borderline rifampicin resistance.
Clinical and Mycobacterium tuberculosis strain characteristics of tuberculosis patients with diabetes mellitus in Changping District, Beijing, China.
Speeding up drug susceptibility testing in Mycobacterium tuberculosis using RNA biomarkers.
Outbreak Caused by Multidrug-Resistant Mycobacterium Tuberculosis with Unusual Combination of Resistance Mutations, Northern Argentina, 2006-2022.
associated with resistance
Multi-drug resistance and compensatory mutations in Mycobacterium tuberculosis in Vietnam.
Combination therapy delays antimicrobial resistance after adaptive laboratory evolution of Staphylococcus aureus.
Mutation in rpoB was associated with high-level rifampicin resistance
Diagnostic Performance of TBseq Test for Tuberculosis Detection and Drug Resistance Prediction
Multiple rpoB mutations associated with RIF resistance
Direct detection from sputum for drug-resistant Mycobacterium tuberculosis using a CRISPR-Cas14a-based approach.
Mutation detected in RIF-resistant isolates.
Classic and new candidate markers for drug resistance in a large cohort of leprosy patients from the Amazon state, Brazil.
Previously reported as a rifampicin resistance mutation
In Vitro and In Silico Evaluation of Isatin-Derived Spirooxindoles as Antituberculosis Drug Candidates.
Trehalose catalytic shift inherently enhances phenotypic heterogeneity and multidrug resistance in Mycobacterium tuberculosis.
The L452P mutation in the rpoB gene was identified in Flux RIF #1 and #2 bacilli.
Dissecting rifampicin heteroresistance in Mycobacterium tuberculosis: integrating whole-genome sequencing with phenotypic and clonal validation.
D435Y mutation was found in isolate 1R and conferred low-level rifampicin resistance.
Surveillance and analysis of drug resistance and drug resistance levels in multidrug resistant tuberculosis on the tropical islands of China.
Whole-genome sequencing and machine learning reveal key drivers of delayed sputum conversion in rifampicin-resistant tuberculosis.
Unraveling Epistatic Interactions Between Sites Under Drug-Dependent Selection in the Mycobacterium tuberculosis Genome.
Mutation rpoB:S450L is associated with RIF resistance
Molecular insights of drug-resistant tuberculosis: genetic mutations and their profile.
Impeding pathways of intrinsic resistance in Escherichia coli confers antibiotic sensitization and resistance proofing.
rpoB mutation leads to rifampicin resistance
Allele-specific effects of mutations in the rifampin resistance-determining region (RRDR) of RpoB on physiology and antibiotic resistance in Enterococcus faecium.
Mutations in the RpoB gene's rifampin resistance-determining region (RRDR) were found to confer rifampin resistance in Enterococcus faecium.
Beyond Hotspot Mutations: Diagnostic Relevance of High Frequency, Low Frequency, and Disputed rpoB Variants in Rifampicin-Resistant Mycobacterium tuberculosis.
Mutations in rpoB are responsible for rifampicin resistance in Mycobacterium tuberculosis.
Molecular characterization of rifampin-resistant Neisseria meningitidis.
All mutations were identified in rifampin-resistant isolates and in vitro-generated mutants.
rpoB
Mutations in the rpoB Gene of Rifampin-Resistant Mycobacterium tuberculosis Strains Isolated Mostly in Asian Countries and Their Rapid Detection by Line Probe Assay.
Genetic antagonism and hypermutability in Mycobacterium smegmatis.
reverted to wild type at high frequency
Sequencing of the rpoB gene in Legionella pneumophila and characterization of mutations associated with rifampin resistance in the Legionellaceae.
mutations in rpoB gene associated with rifampin resistance in Legionella species
Characterization of spontaneous, In vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv.
Low-level resistance to rifampin in Streptococcus pneumoniae.
mutations in rpoB confer rifampin resistance
Rapid detection of rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis isolates in shanghai by using the amplification refractory mutation system.
Direct detection of rifampin-resistant mycobacterium tuberculosis in respiratory specimens by PCR-DNA sequencing.
Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns.
Protective properties of rifampin-resistant rough mutants of Brucella melitensis.
Found in RBM9, RBM11, RBM15, RBM17, RBM19
Rapid determination of rifampin resistance in clinical isolates of Mycobacterium tuberculosis by real-time PCR.
Mutations in rpoB were associated with rifampin resistance
Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa.
Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong.
Detected in multiple isolates
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing.
Mutations in rpoB associated with rifampin resistance.
Evaluation of methods for rapid detection of resistance to isoniazid and rifampin in Mycobacterium tuberculosis isolates collected in the Caribbean.
Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus.
Positive epistasis drives the acquisition of multidrug resistance.
Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints.
Please note that this corresponds to amino acid 458 based on the TIGR annotation of H37Rv.
Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China.
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
Mutations in the beta subunit of RNA polymerase (rpoB) confer resistance to streptolydigin and streptovaricin in Streptomyces lydicus and Streptomyces spectabilis.
Use of the GenoType(R) MTBDRplus assay to assess drug resistance of Mycobacterium tuberculosis isolates from patients in rural Uganda.
An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.
The rpoB mutation was shown to confer heteroresistance to vancomycin and daptomycin in S. aureus.
Staphylococcus aureus rpoB mutants conferring resistance to daptomycin; CARD accession: CARD:3003287
Utility of antibiotic resistance in chlamydial genetics, recombination & transformation
Multiple mutations increase MIC significantly
Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDR.
Rapid diagnosis of extensively drug-resistant tuberculosis by use of a reverse line blot hybridization assay.
Study of Genetic Evolution in Mycobacterium tuberculosis Isolates from Patients with Active Pulmonary Tuberculosis in the Iran and Belarus.
mutations in rpoB gene confer resistance to rifampicin
Mutation analysis of mycobacterial rpoB genes and rifampin resistance using recombinant Mycobacterium smegmatis.
All mutations were experimentally validated in this study.
Microevolution of extensively drug-resistant tuberculosis in Russia.
Mutations promoted from gene entry 'rpoB' (model emitted mutations_found inside genes).
Variations in the occurrence of specific rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolates from patients of different ethnic groups in Kuwait.
Mutations in rpoB were detected by DNA sequencing.
Visual detection of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis strains by use of an asymmetrically split peroxidase DNAzyme.
mutations in rpoB gene confer rifampin resistance
Drug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New Guinea.
Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients.
Evolutionary dynamics of separate and combined exposure of Pseudomonas fluorescens SBW25 to antibiotics and bacteriophage.
Most common mutation in rif-resistant WT and mutS− ancestors
Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: a prospective validation study.
Mutations in rpoB were detected in RMP-resistant M. tuberculosis isolates.
Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa.
Rapid Screening of MDR-TB in Cases of Extra Pulmonary Tuberculosis Using Geno Type MTBDRplus.
Genotypic characterization of drug resistant Mycobacterium tuberculosis in Quebec, 2002-2012.
most common mutation
Whole-genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar.
Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing.
Genotypic Detection of rpoB and katG Gene Mutations Associated with Rifampicin and Isoniazid Resistance in Mycobacterium Tuberculosis Isolates: A Local Scenario (Kelantan).
Development and characterisation of highly antibiotic resistant Bartonella bacilliformis mutants.
Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
Draft genome sequence of Mycobacterium tuberculosis strain B9741 of Beijing B0/W lineage from HIV positive patient from Siberia.
Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China.
A joint cross-border investigation of a cluster of multidrug-resistant tuberculosis in Austria, Romania and Germany in 2014 using classic, genotyping and whole genome sequencing methods: lessons learnt.
Novel Mutation Sites in the Development of Vancomycin-Intermediate Resistance in Staphylococcus aureus.
A Clostridium difficile Lineage Endemic to Costa Rican Hospitals Is Multidrug Resistant by Acquisition of Chromosomal Mutations and Novel Mobile Genetic Elements.
rifampin resistance
Rifampicin-Resistance Mutations in the rpoB Gene in Bacillus velezensis CC09 have Pleiotropic Effects.
Mutations in rpoB confer rifampicin resistance in B. velezensis.
Direct Detection of Rifampin and Isoniazid Resistance in Sputum Samples from Tuberculosis Patients by High-Resolution Melt Curve Analysis.
In vitro and in vivo fitness costs associated with Mycobacterium tuberculosis RpoB mutation H526D.
The mutation H526D in the rpoB gene was associated with reduced Mtb virulence and delayed resuscitation from nutrient starvation.
Genome sequence comparisons of serial multi-drug-resistant Mycobacterium tuberculosis isolates over 21 years of infection in a single patient.
Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples.
Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis.
Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations.
The S531L mutation in rpoB confers resistance to rifampin.
Use of DNA microarray chips for the rapid detection of Mycobacterium tuberculosis resistance to rifampicin and isoniazid.
Combination of commercially available molecular assays and culture based methods in diagnosis of tuberculosis and drug resistant tuberculosis.
Among the five isolates that were resistant to RMP various mutations of the rpoB gene were detected. The types of mutations were similar to those found in a previous study from Greek patients affecting most commonly codons 531 and 526.
Plasmid-based high-resolution melting analysis for accurate detection of rpoB mutations in Mycobacterium tuberculosis isolates from Moroccan patients.
Five rifampicin-resistant isolates lacked mutations in the rpoB amplified region.
Finegoldia magna Isolated from Orthopedic Joint Implant-Associated Infections.
Three strain-specific nucleotide polymorphisms in the rpoB gene were found in the resistant isolate, leading to the following amino acid substitutions: Gln135Arg, Ile629Val, and Gly1179Asp.
Insights into RNA polymerase catalysis and adaptive evolution gained from mutational analysis of a locus conferring rifampicin resistance.
Enhances abortive initiation and reduces promoter clearance
Detection of mutations in the rpoB gene of rifampicin-resistant Mycobacterium tuberculosis strains inhibiting wild type probe hybridization in the MTBDR plus assay by DNA sequencing directly from clinical specimens.
Mutations in the rpoB gene associated with rifampicin resistance
Genotypic Distribution and a Potential Diagnostic Assay of Multidrug-Resistant Tuberculosis in Northern Thailand.
Prevalence and factors associated with multidrug-resistant tuberculosis in South India.
Drug-resistant Mycobacterium tuberculosis and its genotypes isolated from an outbreak in western Thailand.
Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency.
Identification of a predominant genotype of Mycobacterium tuberculosis in Brazilian indigenous population.
Mutations in rpoB are associated with rifampicin resistance.
Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
The D435Y mutation in the rpoB gene is associated with low-level rifampicin resistance.
Clusters of Drug-Resistant Mycobacterium tuberculosis Detected by Whole-Genome Sequence Analysis of Nationwide Sample, Thailand, 2014-2017.
mutation in rpoB associated with rifampin resistance
Evaluation of the Roche cobas MTB and MTB-RIF/INH Assays in Samples from Germany and Sierra Leone.
rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis isolates from rural areas of Zhejiang, China.
Thin-Layer-Agar-Based Direct Phenotypic Drug Susceptibility Testing on Sputum in Eswatini Rapidly Detects Mycobacterium tuberculosis Growth and Rifampicin Resistance Otherwise Missed by WHO-Endorsed Diagnostic Tests.
Detected in 8/28 (28.6%) of confirmed RR isolates
Predicting rifampicin resistance mutations in bacterial RNA polymerase subunit beta based on majority consensus.
Mutations in the rifampicin resistance-determining regions (RRDRs) of RpoB were analyzed.
Whole genome analysis of extensively drug resistant Mycobacterium tuberculosis strains in Peru.
Detection of genomic mutations in katG and rpoB genes among multidrug-resistant Mycobacterium tuberculosis isolates from Tehran, Iran.
Novel tigecycline resistance mechanisms in Acinetobacter baumannii mediated by mutations in adeS, rpoB and rrf.
One SNP was observed in rpoB (G136D)
Expression Dysregulation as a Mediator of Fitness Costs in Antibiotic Resistance.
Generation of Tetracycline and Rifamycin Resistant Chlamydia Suis Recombinants.
Comparison of Culture With Antibiogram to Next-Generation Sequencing Using Bacterial Isolates and Formalin-Fixed, Paraffin-Embedded Gastric Biopsies.
False detection of rifampicin resistance using Xpert(®) MTB/RIF Ultra assay due to an A451V mutation in Mycobacterium tuberculosis.
The A451V (A532V) mutation in the rpoB gene was identified in all three isolates but did not confer rifampicin resistance as confirmed by phenotypic drug susceptibility tests.
Evolution and emergence of multidrug-resistant Mycobacterium tuberculosis in Chisinau, Moldova.
The rpoB S450L mutation confers resistance to rifampin and is part of the MDR phenotype.
Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa.
associated with low-level rifampin resistance
Genetic Diversity of Multidrug-Resistant Pseudomonas aeruginosa Isolates Carrying bla (VIM-2) and bla (KPC-2) Genes That Spread on Different Genetic Environment in Colombia.
Molecular characterization of rpoB gene mutations in isolates from tuberculosis patients in Cubal, Republic of Angola.
mutations in rpoB associated with rifampicin resistance
Genomic Profiling of Mycobacterium tuberculosis Strains, Myanmar.
rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis.
These mutations were identified as contributing to rifampin resistance through experimental validation.
Performance Evaluation of GeneLEAD/Deeplex Myc-TB for Mycobacterium tuberculosis Complex Diagnosis and Drug Susceptibility Testing
A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile.
Associated with rifamycin resistance
A Rapid Drug Resistance Genotyping Workflow for Mycobacterium tuberculosis, Using Targeted Isothermal Amplification and Nanopore Sequencing.
Mutations in rpoB confer resistance to rifampin
Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China.
Deciphering the Molecular Basis for Attenuation of Flavobacterium columnare Strain Fc1723 Used as Modified Live Vaccine against Columnaris Disease.
Two mutations in rpoB were identified, which are associated with rifampin resistance.
A modified decision tree approach to improve the prediction and mutation discovery for drug resistance in Mycobacterium tuberculosis.
Transmission of multidrug-resistant Mycobacterium tuberculosis in Wuhan, China: A retrospective molecular epidemiological study.
Application of Amplicon-Based Targeted NGS Technology for Diagnosis of Drug-Resistant Tuberculosis Using FFPE Specimens.
high-confidence mutation
Proteomic Signatures of Antimicrobial Resistance in Yersinia pestis and Francisella tularensis.
Mutation in rpoB leads to rifampicin resistance in FSC232.
Comparative Genomic Reveals Clonal Heterogeneity in Persistent Staphylococcus aureus Infection.
Mycobacterium tuberculosis Lineages Associated with Mutations and Drug Resistance in Isolates from India.
First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda.
Genomic analysis of Staphylococcus aureus isolates from bacteremia reveals genetic features associated with the COVID-19 pandemic.
Whole genome sequencing analysis of Mycobacterium tuberculosis reveals circulating strain types and drug-resistance mutations in the Philippines.
Common mutations underlying MDR-TB for rifampicin.
Drug-resistance characteristics, genetic diversity, and transmission dynamics of multidrug-resistant or rifampicin-resistant Mycobacterium tuberculosis from 2019 to 2021 in Sichuan, China.
Mutation in rpoB gene associated with rifampicin resistance
Rifaximin prophylaxis causes resistance to the last-resort antibiotic daptomycin.
Mutations in rpoB lead to daptomycin resistance in VREfm.
Genetic diversities and drug resistance in Mycobacterium bovis isolates from zoonotic tuberculosis using whole genome sequencing.
Leveraging large-scale Mycobacterium tuberculosis whole genome sequence data to characterise drug-resistant mutations using machine learning and statistical approaches.
Analysis of antibiotic susceptibility and genomic characteristics of Helicobacter pylori by whole-genome resequencing in Northern China.
Genotypes and drug resistance pattern of Mycobacterium tuberculosis complex among clinically diagnosed pulmonary tuberculosis patients.
High-throughput method characterizes hundreds of previously unknown antibiotic resistance mutations.
rpoB mutations were selected for by rifampicin
rpoB mutations and their association with rifampicin resistance in clinical Staphylococcus epidermidis.
Mutations in the rpoB gene were associated with rifampicin resistance in clinical S. epidermidis isolates.
rpoB
Genetic diversity and transmission pattern of multidrug-resistant tuberculosis based on whole-genome sequencing in Wuhan, China.
Impact of rpoB gene mutations and Rifampicin-resistance levels on treatment outcomes in Rifampicin-resistant tuberculosis.
Mutations in the rpoB gene were associated with rifampicin resistance and treatment outcomes.
Adoption of an in-silico analysis approach to assess the functional and structural impacts of rpoB-encoded protein mutations on Chlamydia pneumoniae sensitivity to antibiotics.
All mutations were identified in previous studies and analyzed in-silico.
Clinical characteristics and genomic epidemiological survey of tuberculosis in Wuzhou, China, 2022.
Next-generation rifamycins for the treatment of mycobacterial infections.
Genomic characterization of multidrug-resistant tuberculosis in Shanghai, China: antibiotic resistance, virulence and transmission.
Clostridioides difficile evolution in a tertiary German hospital through a retrospective genomic characterization.
Mutations associated with resistance to rifampicin and isoniazid identified in strains of the Mycobacterium tuberculosis complex by GenoType MTBDRplus in Panama, 2015-2021.
Genomic epidemiology analysis of extremely drug-resistant tuberculosis in Shanghai, China.
Compensatory mutations in rpoB were associated with increased transmissibility of EDR-TB strains.
Is Rifampin (Rifampicin) Essential for the Treatment of Rhodococcus equi Infections in Foals? A Critical Review of the Role of Rifampin.
Mutations in rpoB are associated with rifampin resistance in R. equi.
Whole-Genome Sequence-Based Diversity of Mycobacterium tuberculosis Strains Isolated from a Central Western Region of Mexico.
Mixed infections and heteroresistance of Mycobacterium tuberculosis among multidrug-resistant tuberculosis in China: a genomic epidemiology study.
Off-label evaluation of the BD MAX MDR-TB assay for rapid diagnosis of rifampicin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in a high-volume reference laboratory.
Detected in a RIF-R isolate
Comprehensive analysis of mutations associated with rifampicin- and isoniazid-resistant tuberculosis in a high-burden setting.
borderline mutation
Genomic characterization of XDR Mycobacterium tuberculosis isolates in Argentina (2006-2015).
Whole genome sequencing-based detection of extensively drug-resistant tuberculosis from Ethiopia.
Association of D516V, H526Y, and S531L rpoB gene polymorphisms and risk factors with rifampicin resistance in Mycobacterium tuberculosis isolates from pulmonary TB patients in Northwest Amhara, Ethiopia: cross-sectional study.
Mutation detected via ARMS-PCR.
Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997).
Mutations in rpoB are associated with rifampin resistance.
Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis.
Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis.
Characterization of mutations in the rpoB gene associated with rifampin resistance in Rhodococcus equi isolated from foals.
Mutations in the rpoB gene are associated with rifampin resistance in Rhodococcus equi.
New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis.
Mutations in rpoB gene associated with rifampin resistance
High-efficiency generation of antibiotic-resistant strains of Streptococcus pneumoniae by PCR and transformation.
Emergence of rifampin-resistant Rhodococcus equi with several types of mutations in the rpoB gene among AIDS patients in northern Thailand.
Novel mutation in R. equi
Effect of rpoB Mutations Conferring Rifampin Resistance on Fitness of Mycobacterium tuberculosis.
Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay.
Mutations in the rpoB gene confer rifampin resistance
Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis.
No mutations were detected in the entire rpoB gene of rifampin-resistant BU-434/L 2.
Tuberculosis due to resistant Haarlem strain, Tunisia.
Multidrug-resistant tuberculosis detection, Latvia.
Mutations detected by line probe assay for rpoB gene.
In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus.
Mutations in rpoB confer resistance to rifampin.
Rifampin-resistant Neisseria meningitidis.
Mutations in rpoB gene confer resistance to rifampin.
Evaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis.
Molecular characterisation of Mycobacterium tuberculosis isolates in the First National Survey of Anti-tuberculosis Drug Resistance from Venezuela.
Multidrug-resistant Mycobacterium tuberculosis, Bangui, Central African Republic.
Mutations in rpoB are responsible for rifampin resistance.
Detection of multidrug resistance in Mycobacterium tuberculosis.
mutations in the 81-bp core region of rpoB are responsible for resistance in at least 96% of RIF-resistant M. tuberculosis isolates
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Lateral gene transfer in vitro in the intracellular pathogen Chlamydia trachomatis.
Single nucleotide change in the rpoB gene
Dramatic activation of antibiotic production in Streptomyces coelicolor by cumulative drug resistance mutations.
Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn's disease.
The mutation C1367T in the rpoB gene of MAP strain 18 leads to resistance to rifabutin and rifampicin.
Large scale variation in Enterococcus faecalis illustrated by the genome analysis of strain OG1RF.
Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis.
Mutations in rpoB gene were detected in Genotype MTBDR and MTBDR plus tests.
Characterization of RPO B gene for detection of rifampicin drug resistance by SSCP and sequence analysis.
Mutations in the rpoB gene were associated with rifampicin resistance.
Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso.
Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones.
Associations between Mycobacterium tuberculosis strains and phenotypes.
Mutations in rpoB gene associated with rifampin resistance
The genome of Streptococcus mitis B6--what is a commensal?
Molecular characterization of resistance to Rifampicin in an emerging hospital-associated Methicillin-resistant Staphylococcus aureus clone ST228, Spain.
Additional mutations in rpoB are associated with high-level rifampicin resistance
High-resolution melting curve analysis for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates.
Mutations in rpoB gene are associated with rifampin resistance.
Rifaximin disc diffusion test for in vitro susceptibility testing of Clostridium difficile.
Engineering Streptomyces coelicolor for heterologous expression of secondary metabolite gene clusters.
Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori.
Mutations in rpoB are responsible for rifamycin resistance in H. pylori.
Rapid identification of mycobacteria and drug-resistant Mycobacterium tuberculosis by use of a single multiplex PCR and DNA sequencing.
Molecular characteristics of rifampin- and isoniazid-resistant mycobacterium tuberculosis strains isolated in Vietnam.
Use of multiplex allele-specific polymerase chain reaction (MAS-PCR) to detect multidrug-resistant tuberculosis in Panama.
Detected in 53/67 isolates
Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test.
Molecular characterization of rifampicin-resistant Staphylococcus aureus isolates in a Chinese teaching hospital from Anhui, China.
mutations in rpoB gene are associated with rifampicin resistance
Increased survival of antibiotic-resistant Escherichia coli inside macrophages.
The mutation was found to confer resistance to rifampin.
Genotypic detection of rifampicin-resistant M. tuberculosis strains in Syrian and Lebanese patients.
Mutations in the rpoB gene were identified in rifampicin-resistant M. tuberculosis isolates.
Rapid genotypic detection of rpoB and katG gene mutations in Mycobacterium tuberculosis clinical isolates from Northern India as determined by MAS-PCR.
Cultivation of Staphylococcus epidermidis in the Human Spaceflight Environment Leads to Alterations in the Frequency and Spectrum of Spontaneous Rifampicin-Resistance Mutations in the rpoB Gene.
Mutations in the rpoB gene leading to rifampicin resistance in S. epidermidis.
Mutational Consequences of Ciprofloxacin in Escherichia coli.
Mutations in rpoB contribute to rifampin resistance
Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
Mutations in the rpoB gene were identified as the cause of rifampicin resistance in Mycobacterium tuberculosis isolates.
Prevalence of Drug Resistance Mycobacterium Tuberculosis among Patients Seen in Coast Provincial General Hospital, Mombasa, Kenya.
Mutation in rpoB gene associated with rifampicin resistance.
De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.
Mutation in the rifampin resistance-determining region (RRDR) of the rpoB gene
Structural basis for rifamycin resistance of bacterial RNA polymerase by the three most clinically important RpoB mutations found in Mycobacterium tuberculosis.
The wild-type rpoB gene is susceptible to rifampicin.
Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis sensitive and resistant Beijing type from a patient with pulmonary tuberculosis.
FIND Tuberculosis Strain Bank: a Resource for Researchers and Developers Working on Tests To Detect Mycobacterium tuberculosis and Related Drug Resistance.
Rapid Sputum Multiplex Detection of the M. tuberculosis Complex (MTBC) and Resistance Mutations for Eight Antibiotics by Nucleotide MALDI-TOF MS.
Comprehensive Whole-Genome Sequencing and Reporting of Drug Resistance Profiles on Clinical Cases of Mycobacterium tuberculosis in New York State.
Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition.
Mutation in rpoB gene leading to rifampicin resistance
Multidrug-resistant bacteria compensate for the epistasis between resistances.
Confers resistance to rifampicin
Diagnostic Performance of the GenoType MTBDRplus and MTBDRsl Assays to Identify Tuberculosis Drug Resistance in Eastern China.
Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand.
Frequency and Type of Disputed rpoB Mutations in Mycobacterium tuberculosis Isolates from South Korea.
Disputed rpoB mutations causing low-level resistance to rifampin
Transmission is a Noticeable Cause of Resistance Among Treated Tuberculosis Patients in Shanghai, China.
Antimicrobial resistance determinants and susceptibility profiles of pneumococcal isolates recovered in Trinidad and Tobago.
A change in the rpoB gene (H499Y) resulted in resistance to rifampicin.
Mutations in rpoB and katG genes of multidrug resistant mycobacterium tuberculosis undetectable using genotyping diagnostic methods.
All mutations were identified through sequencing and are associated with rifampicin resistance.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Extensively drug resistant tuberculosis in Mali: a case report.
Dynamics of Extensive Drug Resistance Evolution of Mycobacterium tuberculosis in a Single Patient During 9 Years of Disease and Treatment.
Extreme Antagonism Arising from Gene-Environment Interactions.
Mutations in rpoB confer resistance to rifampicin
Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis Isolates from Moroccan Patients: Systematic Review.
Other mutations were found in a limited number and had frequencies of less than 1% among phenotypically resistant isolates.
Mutant RNA polymerase can reduce susceptibility to antibiotics via ppGpp-independent induction of a stringent-like response.
These mutations in rpoB were shown to reduce susceptibility to ciprofloxacin through a ppGpp-independent stringent-like response.
Comparative Analytical Evaluation of Four Centralized Platforms for the Detection of Mycobacterium tuberculosis Complex and Resistance to Rifampicin and Isoniazid.
Genomic Insights Into Last-Line Antimicrobial Resistance in Multidrug-Resistant Staphylococcus and Vancomycin-Resistant Enterococcus.
Disputed rpoB Mutations in Mycobacterium tuberculosis and Tuberculosis Treatment Outcomes.
Mutations in the rpoB gene were associated with rifampin resistance in Mycobacterium tuberculosis.
Five-year microevolution of a multidrug-resistant Mycobacterium tuberculosis strain within a patient with inadequate compliance to treatment.
Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan.
All mutations are in the rifampicin resistance determining region (RRDR)
Rarity of rpoB Mutations Outside the Rifampicin Resistance-Determining Region of Mycobacterium tuberculosis Isolates from Patients Responding Poorly to First-Line Tuberculosis Regimens in Beijing, China: A Retrospective Study.
Whole genome sequencing of clinical samples reveals extensively drug resistant tuberculosis (XDR TB) strains from the Beijing lineage in Nigeria, West Africa.
Polyribosome-Dependent Clustering of Membrane-Anchored RNA Degradosomes To Form Sites of mRNA Degradation in Escherichia coli.
The Spectrum of Spontaneous Rifampin Resistance Mutations in the Bacillus subtilis rpoB Gene Depends on the Growth Environment.
Mutations in the rpoB gene were found to confer rifampin resistance.
Analysis of the application of a gene chip method for detecting Mycobacterium tuberculosis drug resistance in clinical specimens: a retrospective study.
Analysing the fitness cost of antibiotic resistance to identify targets for combination antimicrobials.
The H526Y mutation in rpoB was identified as a cause of rifampicin resistance.
Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010/11 to 2018/19).
Mutations in rpoB contribute to rifampicin resistance.
Putative extensive and pre-extensive drug resistant-tuberculosis associated with unusual genotypes on the Thailand-Myanmar border.
Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century.
The Structural Basis of Mycobacterium tuberculosis RpoB Drug-Resistant Clinical Mutations on Rifampicin Drug Binding.
All mutations were identified in the RIF resistance-determining region (RRDR) of rpoB.
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis.
Virulence Determinants in Staphylococcus aureus Clones Causing Osteomyelitis in Italy.
Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Complex Drug Resistance from Early Positive Liquid Cultures.
Global evolutionary dynamics and resistome analysis of Clostridioides difficile ribotype 017.
Molecular Epidemiology and Antimicrobial Resistance of Clostridioides difficile in Hospitalized Patients From Mexico.
Evolution and spread of a highly drug resistant strain of Mycobacterium tuberculosis in Papua New Guinea.
associated with Rifampicin resistance
Identification of echinoderm metabolites as potential inhibitors targeting wild-type and mutant forms of Escherichia coli RNA polymerase (RpoB) for tuberculosis treatment.
Mutations in RpoB were analyzed for their impact on binding affinity of echinoderm metabolites.
Dissecting the genetic features and evolution of Staphylococcus aureus sequence type 88: a global perspective.
Found in one rifampicin-resistant ST88 isolate.
The tigecycline resistance mechanisms in Gram-negative bacilli.
associated with tigecycline resistance
A mutation in RNA polymerase imparts resistance to β-lactams by preventing dysregulation of amino acid and nucleotide metabolism.
Whole genomic analysis uncovers high genetic diversity of rifampicin-resistant Mycobacterium tuberculosis strains in Botswana.
Evaluation of the cobas MTB and MTB-RIF/INH assay in clinical samples for the detection of Mycobacterium tuberculosis in respiratory specimens.
Detected in strain TB 6466
Genotypic drug resistance and transmission clusters of Mycobacterium tuberculosis isolates among Ethiopian returnees from Saudi Arabia.
Identification of genetic mutations conferring tedizolid resistance in MRSA mutants.
Antibiotic Resistance and Genetic Determinants of Helicobacter pylori in Oman: Insights from Phenotypic and Whole-Genome Analysis.
Patterns of compensatory mutations in rpoA/B/C genes of multidrug resistant M. tuberculosis in Uganda.
Mutations in rpoB are associated with rifampicin resistance.
RpoB mutation patterns in Rifampicin-resistant tuberculosis: a Jiangxi Province study, 2021-2023.
Mutations in the rpoB gene are associated with rifampicin resistance
Allele-Specific Effects of Mutations in the Rifampin Resistance-Determining Region (RRDR) of RpoB on Physiology and Antibiotic Resistance in Enterococcus faecium.
Mutations in the rifampin resistance-determining region (RRDR) of RpoB confer resistance to rifampin.
Rapid, accurate, and reproducible de novo prediction of resistance to antituberculars.
Mutations in rpoB gene associated with rifampicin resistance
Correlation Between Xpert MTB/RIF Results and rpoB Mutations within Probe-Targeted Regions in Mycobacterium tuberculosis Isolates from Sichuan Basin.
Mutations in the rpoB gene are responsible for rifampicin resistance.
Characteristics of compensatory mutations in rifampicin-resistant tuberculosis and their association with compensated transmission in Ningbo, China.
putative compensatory mutation
Genomic characterization and epidemiology of Mycobacterium tuberculosis lineage 2 isolates from Kazakhstan.
Most prevalent mutation in RR-determining region
Assessment of target-enrichment library preparation and next-generation sequencing of paraffin-embedded gastric biopsies for H. pylori diagnosis and evaluation of virulome and resistome.
Detected in sample 12
Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in Alaska.
Mutations in rpoB are associated with rifampin resistance.
Tracking the evolution of an extensively drug-resistant cross-border Mycobacterium tuberculosis cluster, Europe, January 2016 up to August 2025: implications for European surveillance.
Patterns of compensatory mutations in rpoA/B/C genes of multidrug resistant M. tuberculosis in Uganda.
Some mutations are classified as low-level resistance-conferring.
Characterization of Drug Resistance Patterns, Mutation Profiles and Prevalence of Mycobacterium tuberculosis in Shaoxing.
A novel one-tube nested fluorescence melting curve analysis for rapid detection of drug-resistant Mycobacterium tuberculosis.
All mutations were confirmed by DNA sequencing.
Genetic identification of mutations and MLST types associated with decreased susceptibility to ceftriaxone in Neisseria gonorrhoeae.
Mutations in RpoB are associated with ceftriaxone resistance.
Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs.
Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.
associated with high-level rifampicin resistance
Molecular detection and characterization of resistant genes in Mycobacterium tuberculosis complex from DNA isolated from tuberculosis patients in the Eastern Cape province South Africa.
Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: a retrospective study.
Mutations in the 81 bp RRDR of rpoB gene were associated with rifampicin resistance.
Assessment of the genotype MTBDRplus assay for rifampin and isoniazid resistance detection on sputum samples in Cote d'Ivoire.
Evaluation of gene mutations involved in drug resistance in mycobacterium tuberculosis strains derived from tuberculosis patients in mazandaran, iran, 2013.
Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting.
Mutations in rpoB are associated with rifampicin resistance.
Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis.
Linking system-wide impacts of RNA polymerase mutations to the fitness cost of rifampin resistance in Pseudomonas aeruginosa.
All mutations in rpoB were associated with reduced transcriptional efficiency and fitness costs.
Added value of whole-genome sequencing for management of highly drug-resistant TB.
Strong evidence for a causal association with a drug-resistant phenotype
Molecular analysis of codon 548 in the rpoB gene involved in Mycobacterium tuberculosis resistance to rifampin.
The mutation was found in a clinical isolate and validated by constructing recombinant strains.
GWAMAR: genome-wide assessment of mutations associated with drug resistance in bacteria.
Tuberculous spondylitis in Russia and prominent role of multidrug-resistant clone Mycobacterium tuberculosis Beijing B0/W148.
Low resistance to first and second line anti-tuberculosis drugs among treatment naive pulmonary tuberculosis patients in southwestern Uganda.
One isolate showed isoniazid resistance via MTBDR plus, linked to katG mutation
Clinical application of whole-genome sequencing to inform treatment for multidrug-resistant tuberculosis cases.
Understanding Rifampicin Resistance in Tuberculosis through a Computational Approach.
Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan.
Mutation in the rifampicin-resistance determining region (RRDR)
Convergent adaptation in the dominant global hospital clone ST239 of methicillin-resistant Staphylococcus aureus.
Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrations.
mutations in the rpoB gene are associated with rifampicin resistance
Report of rpoB mutation in clinically suspected cases of drug resistant leprosy: a study from Eastern India.
mutation in rpoB gene associated with rifampicin resistance
Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosis.
Mutations conferring resistance to first- and second-line drugs in multidrug-resistant Mycobacterium tuberculosis clinical isolates in southeast Mexico.
Application of Deletion- Targeted Multiplex PCR technique for detection of Mycobacterium tuberculosis Beijing strains in samples from tuberculosis patients.
Modified Proofreading PCR for Detection of Point Mutations, Insertions and Deletions Using a ddNTP-Blocked Primer.
Detected in Mycobacterium tuberculosis
Comparative Evaluation of Sloppy Molecular Beacon and Dual-Labeled Probe Melting Temperature Assays to Identify Mutations in Mycobacterium tuberculosis Resulting in Rifampin, Fluoroquinolone and Aminoglycoside Resistance.
Draft Genome Sequence of Mycobacterium tuberculosis Strain E186hv of Beijing B0/W Lineage with Reduced Virulence.
associated with rifampin resistance
Causes and Implications of the Disappearance of Rifampin Resistance in a Rat Model of Methicillin-Resistant Staphylococcus aureus Foreign Body Osteomyelitis.
Mutations in rpoB confer rifampin resistance.
The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?
Mutations in rpoB are associated with rifampicin resistance in Mycobacterium tuberculosis.
Transmitted Extended-Spectrum Extensively Drug-Resistant Tuberculosis in Beijing, China, with Discordant Whole-Genome Sequencing Analysis Results.
Genome Analysis of the First Extensively Drug-Resistant (XDR) Mycobacterium tuberculosis in Malaysia Provides Insights into the Genetic Basis of Its Biology and Drug Resistance.
associated with rifampicin resistance
Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study.
Molecular analysis of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates by multiple allele specific polymerase chain reaction in Puducherry, South India.
Mutations in the rpoB gene were associated with rifampicin resistance in Mycobacterium tuberculosis isolates.
Multidrug-resistant and heteroresistant Mycobacterium tuberculosis and associated gene mutations in Ethiopia.
Molecular profiling of drug resistant isolates of Mycobacterium tuberculosis in the state of Santa Catarina, southern Brazil.
Mutations in rpoB are associated with rifampicin resistance.
Evaluation of GenoType MTBDRplus for the rapid detection of drug-resistant tuberculosis in Ghana.
Phenotypic and genotypic analysis of anti-tuberculosis drug resistance in Mycobacterium tuberculosis isolates in Myanmar.
Whole-genome sequencing targets drug-resistant bacterial infections.
RNA polymerase B subunit gene mutations in biofilm-embedded methicillin-resistant Staphylococcus aureus following rifampin treatment.
Mutations in the rpoB gene were associated with rifampin resistance in biofilm-embedded MRSA isolates.
Emergence of primary drug resistance to rifampicin in Mycobacterium leprae strains from leprosy patients in India.
Mutations identified in rpoB gene in Mycobacterium leprae strains from leprosy patients in India.
Reduced turn-around time for Mycobacterium tuberculosis drug susceptibility testing with a proportional agar microplate assay.
Potential mechanisms of attenuation for rifampicin-passaged strains of Flavobacterium psychrophilum.
Mutations in rpoB are associated with rifampicin resistance and attenuation.
Fitness Cost of Rifampin Resistance in Neisseria meningitidis: In Vitro Study of Mechanisms Associated with rpoB H553Y Mutation.
The H553Y mutation in rpoB confers rifampin resistance.
Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.
Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates.
Microscale insights into pneumococcal antibiotic mutant selection windows.
Single point mutations in rpoB were responsible for rifampicin resistance.
Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment.
Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis.
Mutation in rpoB gene associated with rifampicin resistance.
Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatment.
Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae.
MTBDRplus and MTBDRsl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis.
Detection of multidrug-resistant Mycobacterium tuberculosis strains isolated in Brazil using a multimarker genetic assay for katG and rpoB genes.
associated with rifampicin resistance
Genotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in India.
Mutations in rpoB gene were identified through sequencing and were associated with Rifampicin resistance.
Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
Mutation in rpoB gene contributes to rifampicin resistance.
Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance.
Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.
Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
Primary Multidrug Resistant Tuberculosis and Utility of Line Probe Assay for Its Detection in Smear-Positive Sputum Samples in a Tertiary Care Hospital in South India.
Enhanced Survival of Rifampin- and Streptomycin-Resistant Escherichia coli Inside Macrophages.
Epistasis between antibiotic resistance mutations and genetic background shape the fitness effect of resistance across species of Pseudomonas.
Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.
Rifampin Resistance Mutations Are Associated with Broad Chemical Remodeling of Mycobacterium tuberculosis.
Antimicrobial Resistance Mechanisms
Antibiotic resistance mutations induced in growing cells of Bacillus-related thermophiles.
Characterization of Mutations Conferring Resistance to Rifampin in Mycobacterium tuberculosis Clinical Strains.
Mutations in the rpoB gene were analyzed for their role in rifampin resistance.
Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico.
Genetic diversity and drug susceptibility profiles of Mycobacterium tuberculosis obtained from Saint Peter's TB specialized Hospital, Ethiopia.
Common mutation in RIF resistant isolates
Mycobacterium tuberculosis whole genome sequencing provides insights into the Manila strain and drug-resistance mutations in the Philippines.
Confirmed in the study
Retrospective Analysis of Archived Pyrazinamide Resistant Mycobacterium tuberculosis Complex Isolates from Uganda-Evidence of Interspecies Transmission.
The D435Y mutation is disputed regarding its association with rifampin resistance.
Development and evaluation of novel bio-safe filter paper-based kits for sputum microscopy and transport to directly detect Mycobacterium tuberculosis and associated drug resistance.
How Well Do Routine Molecular Diagnostics Detect Rifampin Heteroresistance in Mycobacterium tuberculosis?
Mutation S450L in rpoB was identified in the study.
Evaluation of GenoType MTBDRplus for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Karachi, Pakistan.
most frequent mutation
Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.
Characterization of Helicobacter pylori strains and their antimicrobial resistance mechanisms
Evolution of resistance mechanisms and biological characteristics of rifampicin-resistant Staphylococcus aureus strains selected in vitro.
Other mutations included H481L, H481Y, S464P, R484H
Whole genome sequencing data and analysis of a rifampicin-resistant Mycobacterium tuberculosis strain SBH162 from Sabah, Malaysia.
Mutation site, S450L, for rifampicin resistance was detected in the rpoB gene.
Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid.
First insights into the genetic characteristics and drug resistance of Mycobacterium tuberculosis population collected during the first national tuberculosis prevalence survey of Lao PDR (2010-2011).
Clonal Confinement of a Highly Mobile Resistance Element Driven by Combination Therapy in Rhodococcus equi.
Confers high-level resistance to rifampin.
Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan.
Pre-detection history of extensively drug-resistant tuberculosis in KwaZulu-Natal, South Africa.
Diversity of Mycobacterium tuberculosis in the Middle Fly District of Western Province, Papua New Guinea: microbead-based spoligotyping using DNA from Ziehl-Neelsen-stained microscopy preparations.
All RIF-resistant samples belonged to the L2/Beijing Lineage.
Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients.
A non-synonymous SNP in the rpoB gene of a blood isolate from Patient R1 was identified, which is associated with rifampin resistance.
Prevalence of mutations in genes associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates.
Genomic diversity of prevalent Staphylococcus epidermidis multidrug-resistant strains isolated from a Children's Hospital in México City in an eight-years survey.
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India.
novel mutation
Spoligotyping and drug sensitivity of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients in the Arsi Zone of southeastern Ethiopia.
A retrospective genomic analysis of drug-resistant strains of M. tuberculosis in a high-burden setting, with an emphasis on comparative diagnostics and reactivation and reinfection status.
Evolution of Mycobacterium tuberculosis complex lineages and their role in an emerging threat of multidrug resistant tuberculosis in Bamako, Mali.
Genomic Analysis of Mycobacterium tuberculosis Isolates and Construction of a Beijing Lineage Reference Genome.
The S450L mutation in rpoB was found in TCDC4, TCDC10, and TCDC11.
Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion.
A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic.
Case Report: Multidrug-Resistant Mycobacterium leprae in a Case of Smear-Negative Relapse.
Molecular characterization of pre-extensive drug resistant Mycobacterium tuberculosis in Northeast Brazil.
Dysbiosis individualizes the fitness effect of antibiotic resistance in the mammalian gut.
Confers resistance to rifampicin
Metabolic Rewiring of Mycobacterium tuberculosis upon Drug Treatment and Antibiotics Resistance.
Prevalence of Beijing Central Asian/Russian Cluster 94-32 among Multidrug-Resistant M. tuberculosis in Kazakhstan.
The positivity rates and drug resistance patterns of Mycobacterium tuberculosis using nucleotide MALDI-TOF MS assay among suspected tuberculosis patients in Shandong, China: a multi-center prospective study.
Resistome, mobilome, and virulome explored in clinical isolates derived from acne patients in Egypt: unveiling unique traits of an emerging coagulase-negative Staphylococcus pathogen.
Mutational Dynamics Related to Antibiotic Resistance in M. tuberculosis Isolates from Serial Samples of Patients with Tuberculosis and Type 2 Diabetes Mellitus.
found in four isolates from individuals with DM2-TB and in one isolate from one individual with TB
Rapid detection of multidrug resistance in tuberculosis using nanopore-based targeted next-generation sequencing: a multicenter, double-blind study.
Most frequent mutation in rpoB
Compensatory evolution in NusG improves fitness of drug-resistant M. tuberculosis.
Mutations in rpoB are associated with rifampicin resistance.
Genomic Insights into Staphylococcus aureus Isolates Exhibiting Diminished Daptomycin Susceptibility.
Patterns and profiles of drug resistance-conferring mutations in Mycobacterium tuberculosis genotypes isolated from tuberculosis-suspected attendees of spiritual holy water sites in Northwest Ethiopia.
Most frequent mutation in RIF-resistant isolates
Comparison of targeted next-generation sequencing and the Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in clinical isolates and sputum specimens.
Transmission characteristics in Tuberculosis by WGS: nationwide cross-sectional surveillance in China.
Mutations in rpoB were identified in MDR/RR-TB isolates.
The complete genome sequence of unculturable Mycoplasma faucium obtained through clinical metagenomic next-generation sequencing.
Consistent with observations in other Mycoplasma species.
Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant Mycobacterium tuberculosis isolates in Wenzhou, China.
Mutations in rpoB are associated with rifampin resistance.
Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study.
Drug Susceptibility and Mutation Profiles in Mycobacterium tuberculosis Isolates from a Tertiary Care Hospital in Kerala, India.
Large-scale statistical analysis of Mycobacterium tuberculosis genome sequences identifies compensatory mutations associated with multi-drug resistance.
This mutation is associated with rifampicin resistance.
Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India.
Infection by a multidrug-resistant Corynebacterium diphtheriae strain: prediction of virulence factors, CRISPR-Cas system analysis, and structural implications of mutations conferring rifampin resistance.
Mutation in rpoB gene causes rifampin resistance
Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay.
Mutations detected in the rpoB gene included Ser531Leu, His526Tyr, His526Asp, and His526Cys.
Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus.
Mutations in the rpoB gene confer rifampin resistance in Staphylococcus aureus.
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from south-central in China.
mutations in the rpoB gene are associated with rifampicin resistance
Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencing.
Mutation in rpoB associated with rifampicin resistance.
Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations.
Direct sequencing for rapid detection of multidrug resistant Mycobacterium tuberculosis strains in Morocco.
Evaluation of the AID TB resistance line probe assay for rapid detection of genetic alterations associated with drug resistance in Mycobacterium tuberculosis strains.
Rifampicin mono-resistant tuberculosis in France: a 2005-2010 retrospective cohort analysis.
Mutations identified in rpoB were associated with rifampicin resistance.
Fitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the β' subunit of RNA polymerase.
Mutations in rpoB are associated with rifampicin resistance
Epistasis between antibiotic resistance mutations drives the evolution of extensively drug-resistant tuberculosis.
Sequence analysis of the drug‑resistant rpoB gene in the Mycobacterium tuberculosis L‑form among patients with pneumoconiosis complicated by tuberculosis.
Concomitant multidrug-resistant pulmonary tuberculosis and susceptible tuberculous meningitis.
A multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimens.
Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results.
all mutations are in the rpoB gene
Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis.
Pyrosequencing for rapid detection of tuberculosis resistance in clinical isolates and sputum samples from re-treatment pulmonary tuberculosis patients.
Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China.
Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis.
mutations in rpoB are associated with resistance to rifampin and rifabutin
Dissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.
The rpoB H481Y mutation was significantly associated with VISA phenotype.
Distinguishing nontuberculous mycobacteria from multidrug-resistant Mycobacterium tuberculosis, China.
Sequence analysis for detection of drug resistance in Mycobacterium tuberculosis complex isolates from the Central Region of Cameroon.
mutated in RIF-resistant isolates
Molecular patterns of multidrug resistance of Mycobacterium tuberculosis in Georgia.
Most common mutation responsible for RIF resistance
Optimizing multiplex SNP-based data analysis for genotyping of Mycobacterium tuberculosis isolates.
Multidrug resistant Mycobacterium tuberculosis: a retrospective katG and rpoB mutation profile analysis in isolates from a reference center in Brazil.
A complete high-quality MinION nanopore assembly of an extensively drug-resistant Mycobacterium tuberculosis Beijing lineage strain identifies novel variation in repetitive PE/PPE gene regions.
Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis.
Mutation in rpoB gene associated with high-level rifampin resistance.
Mutations of rpob Gene Associated with Rifampin Resistance among Mycobacterium Tuberculosis Isolated in Tuberculosis Regional Reference Laboratory in Northeast of Iran during 2015-2016.
Successful Treatment with a High-dose Rifampin-containing Regimen for Pulmonary Tuberculosis with a Disputed rpoB Mutation.
Disputed rpoB mutation
Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.
Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using the Quantamatrix Multiplexed Assay Platform System.
Mixed Mycobacterium tuberculosis-Strain Infections Are Associated With Poor Treatment Outcomes Among Patients With Newly Diagnosed Tuberculosis, Independent of Pretreatment Heteroresistance.
Mutations in the rpoB gene were associated with rifampicin resistance.
Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemia.
Mutation in rpoB was associated with increased vancomycin resistance.
Characterization of rifampin-resistant Staphylococcus aureus nasal carriage in patients receiving rifampin-containing regimens for tuberculosis.
Comprehensive antibiotic-linked mutation assessment by resistance mutation sequencing (RM-seq).
Confirmed by genetic reconstruction
Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis.
rpoB
Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes.
The rpoB-H445Y mutation was identified in rifampicin-resistant Mtb HN878 clones.
A rapid identification technique for drug-resistant Mycobacterium tuberculosis isolates using mismatch specific cleavage enzyme.
Mutations in rpoB are associated with rifampicin resistance.
Phenotypic and genotypic drug sensitivity of Mycobacterium tuberculosis complex isolated from South Omo Zone, Southern Ethiopia.
Efficiently activated ε-poly-L-lysine production by multiple antibiotic-resistance mutations and acidic pH shock optimization in Streptomyces albulus.
Cross-sectional Whole-genome Sequencing and Epidemiological Study of Multidrug-resistant Mycobacterium tuberculosis in China.
Understanding molecular consequences of putative drug resistant mutations in Mycobacterium tuberculosis.
Mutations at position 445 in rpoB are associated with rifampicin resistance.
Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
New epidemic cluster of pre-extensively drug resistant isolates of Mycobacterium tuberculosis Ural family emerging in Eastern Europe.
Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia.
Evolution of Rifampin Resistance in Escherichia coli and Mycobacterium smegmatis Due to Substandard Drugs.
Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis.
Phenotypic and genomic comparison of Photorhabdus luminescens subsp. laumondii TT01 and a widely used rifampicin-resistant Photorhabdus luminescens laboratory strain.
Mutations in rpoB confer rifampicin resistance
Mechanisms of fitness cost reduction for rifampicin-resistant strains with deletion or duplication mutations in rpoB.
Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis.
Line-probe assay and molecular typing reveal a potential drug resistant clone of Mycobacterium tuberculosis in Ethiopia.
Mutation detected in strains with rifampicin resistance
Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108.
RpoB(H481N) mutation was identified as a contributor to the VISA phenotype
Transcriptional Approach for Decoding the Mechanism of rpoC Compensatory Mutations for the Fitness Cost in Rifampicin-Resistant Mycobacterium tuberculosis.
Mutation in rpoB leads to rifampin resistance
First insights on the genetic diversity of MDR Mycobacterium tuberculosis in Lebanon.
Rapid detection of multidrug resistant tuberculosis in respiratory specimens at a tertiary care centre in south coastal Karnataka using Genotype MTBDR plus assay.
Most common mutation in rifampicin resistant isolates
Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization.
Investigation of the rpoB Mutations Causing Rifampin Resistance by Rapid Screening in Mycobacterium Tuberculosis in North-East of Iran.
Whole-Genome Sequencing of Drug-Resistant Mycobacterium tuberculosis Strains, Tunisia, 2012-2016.
Longitudinal Outbreak of Multidrug-Resistant Tuberculosis in a Hospital Setting, Serbia.
Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates.
The D435V mutation was associated with decreased susceptibility to both rifampicin and rifabutin.
Lab-on-a-Film disposable for genotyping multidrug-resistant Mycobacterium tuberculosis from sputum extracts.
Molecular epidemiology and whole genome sequencing analysis of clinical Mycobacterium bovis from Ghana.
Genomic analysis of the emergence of drug-resistant strains of Mycobacterium tuberculosis in the Middle East.
Cryptic Resistance Mutations Associated With Misdiagnoses of Multidrug-Resistant Tuberculosis.
noncanonical RIF resistance mutation
Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
Whole genome sequencing identifies bacterial factors affecting transmission of multidrug-resistant tuberculosis in a high-prevalence setting.
Acquired at least twice
Speeding up the diagnosis of multidrug-resistant tuberculosis in a high-burden region with the use of a commercial line probe assay.
High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India.
Mutations in rpoB gene were identified as a cause of rifampicin resistance.
Prevalence and molecular characterization of multidrug-resistant M. tuberculosis in Jiangxi province, China.
Whole genome sequencing Mycobacterium tuberculosis directly from sputum identifies more genetic diversity than sequencing from culture.
Rifampin resistance and its fitness cost in Riemerella anatipestifer.
Some mutations were found to confer varying levels of fitness costs.
Fitness of Spontaneous Rifampicin-Resistant Staphylococcus aureus Isolates in a Biofilm Environment.
Mutation detected in RifR1 and RifR2
Transmission and Drug Resistance Genotype of Multidrug-Resistant or Rifampicin-Resistant Mycobacterium tuberculosis in Chongqing, China.
Genomic characterization of two community-acquired methicillin-resistant Staphylococcus aureus with novel sequence types in Kenya.
First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB.
An in silico analysis of rpoB mutations to affect Chlamydia trachomatis sensitivity to rifamycin.
Prevalence and genetic basis of first-line drug resistance of Mycobacterium tuberculosis in Ca Mau, Vietnam.
MycoVarP: Mycobacterium Variant and Drug Resistance Prediction Pipeline for Whole-Genome Sequence Data Analysis.
Natural Products Lysobactin and Sorangicin A Show In Vitro Activity against Mycobacterium abscessus Complex.
Concordance between Antimicrobial Resistance Phenotype and Genotype of Staphylococcus pseudintermedius from Healthy Dogs.
associated with reduced susceptibility to vancomycin
Distribution and frequency of common mutations in rpoB gene of Mycobacterium tuberculosis detected by Xpert MTB/RIF and identification of residential areas of rifampicin resistant-TB cases: A first retrospective study from Mizoram, Northeast India.
Mutation detected in probe A region.
rpoB Mutations are Associated with Variable Levels of Rifampin and Rifabutin Resistance in Mycobacterium tuberculosis.
Genomic analysis of Mycobacterium tuberculosis variant bovis strains isolated from bovine in the state of Mato Grosso, Brazil.
associated with rifampicin resistance
Genome-resolved insight into the reservoir of antibiotic resistance genes in aquatic microbial community.
Purine Nucleosides Interfere with c-di-AMP Levels and Act as Adjuvants To Re-Sensitize MRSA To β-Lactam Antibiotics.
Comparative genomics of drug-resistant strains of Mycobacterium tuberculosis in Ecuador.
Ultrasensitive Detection of Multidrug-Resistant Mycobacterium tuberculosis Using SuperSelective Primer-Based Real-Time PCR Assays.
Drug Resistance and Molecular Characteristics of Mycobacterium tuberculosis: A Single Center Experience.
TBProfiler for automated calling of the association with drug resistance of variants in Mycobacterium tuberculosis.
Variant classified as associated with resistance in the WHO catalogue.
Antibiotic perseverance increases the risk of resistance development.
Mutations in rpoB were identified as the mechanism of rifampicin resistance.
Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration.
mutations in rpoB gene associated with rifampin resistance
Analysis of drug resistance among difficult-to-treat tuberculosis patients in Ghana identifies several pre-XDR TB cases.
Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
Mutations in rpoB That Confer Rifampicin Resistance Can Alter Levels of Peptidoglycan Precursors and Affect β-Lactam Susceptibility.
Confers high-level resistance to both CEF and RIF
New insights on tuberculosis transmission dynamics and drug susceptibility profiles among the prison population in Southern Brazil based on whole-genome sequencing.
Investigation of Multi-Subunit Mycobacterium tuberculosis DNA-Directed RNA Polymerase and Its Rifampicin Resistant Mutants.
All mutations are located in the RIF-resistance-determining region (RRDR) of rpoB.
Clinical utility of target-based next-generation sequencing for drug-resistant TB.
Mutations in rpoB were identified as a key determinant of rifampicin resistance.
A rapid, accurate, and low-cost method for detecting Mycobacterium tuberculosis and its drug-resistant genes in pulmonary tuberculosis: Applications of MassARRAY DNA mass spectrometry.
Consistent with phenotypic results
Poor correlation with phenotype
The Evolution and Transmission Dynamics of Multidrug-Resistant Tuberculosis in an Isolated High-Plateau Population of Tibet, China.
RpoB Gln409Arg is a common rifampicin resistance mutation.
Discrepancy in the transmissibility of multidrug-resistant mycobacterium tuberculosis in urban and rural areas in China.
No significant association with MDR-TB clustering
Synthesis and Characterization of Phenylalanine Amides Active against Mycobacterium abscessus and Other Mycobacteria.
Mutation in RpoB subunit of RNAP responsible for resistance to MMV688845
FLASH-TB: an Application of Next-Generation CRISPR to Detect Drug Resistant Tuberculosis from Direct Sputum.
The relative transmission fitness of multidrug-resistant Mycobacterium tuberculosis in a drug resistance hotspot.
mutation in the RNA polymerase beta subunit
Drug Resistance in Tuberculous Lymphadenitis: Molecular Characterization.
Evolution and epidemic success of Mycobacterium tuberculosis in eastern China: evidence from a prospective study.
Mutations in rpoB are associated with rifampicin resistance.
A Clinically Selected Staphylococcus aureus clpP Mutant Survives Daptomycin Treatment by Reducing Binding of the Antibiotic and Adapting a Rod-Shaped Morphology.
The A477D substitution in RpoB was shown to cause resistance to rifampin.
Profile and Frequency of Mutations Conferring Drug-Resistant Tuberculosis in the Central, Southeastern and Eastern Ethiopia.
Heteroresistance to rifampicin & isoniazid in clinical samples of patients with presumptive drug-resistant tuberculosis in Central India.
Mutation patterns of resistance genes for macrolides, aminoglycosides, and rifampicin in non-tuberculous mycobacteria isolates from Kenya.
Mycobacterium tuberculosis Adaptation in Response to Isoniazid Treatment in a Multi-Stress System That Mimics the Host Environment.
The MDR strain has an amino acid change in RpoB (D516V).
Adaptive Laboratory Evolution of Staphylococcus aureus Resistance to Vancomycin and Daptomycin: Mutation Patterns and Cross-Resistance.
Mutation detected in derivatives selected for vancomycin.
In Vivo Emergence of Dual Resistance to Rifampin and Levofloxacin in Osteoarticular Cutibacterium avidum.
Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study.
mutations_in_rpoB_are_associated_with_rifampicin_resistance
Prevalence of Mycobacterium tuberculosis mutations associated with isoniazid and rifampicin resistance: A systematic review and meta-analysis.
Using Microfluidic Chip and Allele-Specific PCR to Rapidly Identify Drug Resistance-Associated Mutations of Mycobacterium tuberculosis.
Selective Pressure by Rifampicin Modulates Mutation Rates and Evolutionary Trajectories of Mycobacterial Genomes.
Mutations in rpoB were associated with increased rifampicin resistance.
GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis.
Mutations in rpoB gene that affect rifampicin resistance detection by Xpert Ultra.
Host-pathogen relationship in retreated tuberculosis with major rifampicin resistance-conferring mutations.
Both mutations are linked to rifampicin resistance and differ in prevalence across Mtb lineages.
Molecular Analysis of Anti-Tuberculosis Drug Resistance of Mycobacterium tuberculosis Isolated in the Republic of Korea.
High-resolution landscape of an antibiotic binding site.
These mutations increase sensitivity to rifampicin, leading to bactericidal effects.
Analysis of Drug-Resistance Characteristics and Genetic Diversity of Multidrug-Resistant Tuberculosis Based on Whole-Genome Sequencing on the Hainan Island, China.
Comparative Study on Tuberculosis Drug Resistance and Molecular Detection Methods Among Different Mycobacterium Tuberculosis Lineages.
Insight into the drug-resistant characteristics and genetic diversity of multidrug-resistant Mycobacterium tuberculosis in China.
Genomic markers of drug resistance in Mycobacterium tuberculosis populations with minority variants.
Detected in 65/1831 strains
Mixed infections in genotypic drug-resistant Mycobacterium tuberculosis.
Characterization of a Tigecycline-, Linezolid- and Vancomycin-Resistant Clinical Enteroccoccus faecium Isolate, Carrying vanA and vanB Genes.
Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure.
Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach.
Molecular Characteristics and Prevalence of Rifampin Resistance in Staphylococcus aureus Isolates from Patients with Bacteremia in South Korea.
mutations in the rifampin resistance-determining region (RRDR) of the rpoB gene
Genomic Characterization of Drug-Resistant Mycobacterium tuberculosis L2/Beijing Isolates from Astana, Kazakhstan.
This mutation is associated with rifampicin resistance.
Basal level of ppGpp coordinates Escherichia coli cell heterogeneity and ampicillin resistance and persistence.
The mutation D675A in rpoB was identified as a suppressor mutation in the ppGpp 0 strain, which restored ampicillin MIC and reduced persistence.
Molecular characterization of genetic mutations with fitness loss in pulmonary tuberculosis patients associated with HIV co-infection in Northwest Amhara, Ethiopia.
Detected in MDR-TB isolates
Evaluating the Sensitivity of Different Molecular Techniques for Detecting Mycobacterium tuberculosis Complex in Patients with Pulmonary Infection.
Phenotype versus genotype discordant rifampicin susceptibility testing in tuberculosis: implications for a diagnostic accuracy.
Mutations in rpoB associated with rifampicin resistance
The MAGMA pipeline for comprehensive genomic analyses of clinical Mycobacterium tuberculosis samples.
A preliminary evaluation of targeted nanopore sequencing technology for the detection of Mycobacterium tuberculosis in bronchoalveolar lavage fluid specimens.
Adaptive laboratory evolution of Salmonella enterica in acid stress.
Mutation in rpoB was observed in EL2.
Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique.
A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools.
Epidemiology and genetic diversity of invasive Neisseria meningitidis strains circulating in Portugal from 2003 to 2020.
Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis.
mutations in rpoB are associated with rifampicin resistance
Bedaquiline for treatment of non-tuberculous mycobacteria (NTM): a systematic review and meta-analysis.
Rapid detection of drug-resistant Mycobacterium tuberculosis by Modified MODS assay suitable for resource-poor settings.
Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach.
mutations in the RRDR region
Genetic Determinants in MRSA Carriage and Their Association with Decolonization Outcome.
Insights into the in-vitro Susceptibility and Drug-Drug Interaction Profiles Against Drug-Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates in Amhara, Ethiopia.
Commensal antimicrobial resistance mediates microbiome resilience to antibiotic disruption.
Simultaneous species identification and detection of rifampicin resistance in staphylococci by sequencing of the rpoB gene.
mutations in rpoB gene associated with rifampicin resistance
Comparative genomics and drug resistance of a geographic variant of ST239 methicillin-resistant Staphylococcus aureus emerged in Russia.
Mutation in rpoB gene leads to rifampicin resistance.
First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances.
Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis.
Genetic basis of rifampicin resistance in methicillin-resistant Staphylococcus aureus suggests clonal expansion in hospitals in Cape Town, South Africa.
novel
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated in Nepal.
Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB.
Mutations in rpoB were identified in rifampin-resistant mutants.
Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis.
RpoB mutations are associated with rifampin resistance
Estimating fitness by competition assays between drug susceptible and resistant Mycobacterium tuberculosis of predominant lineages in Mumbai, India.
Comparison of line probe assay with liquid culture for rapid detection of multi-drug resistance in Mycobacterium tuberculosis.
Mutations in rpoB gene confer resistance to rifampicin.
Evolution of Rifampicin Resistance and Its Ecological Consequences
Mutations in rpoB alter RNA polymerase function, affecting fitness in different environmental contexts.
The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks.
mutations in rpoB gene are associated with rifampicin resistance
Activation and products of the cryptic secondary metabolite biosynthetic gene clusters by rifampin resistance (rpoB) mutations in actinomycetes.
These mutations were found to activate cryptic secondary metabolite biosynthetic gene clusters and increase antibiotic production in various actinomycetes.
Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa.
From multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide study.
MDR TB transmission, Singapore.
Rifampin-resistant Mycobacterium bovis BCG-induced disease in HIV-infected infant, Vietnam.
Mutation associated with rifampin resistance
Resistance of Mycobacterium tuberculosis to antibiotics in Lao PDR: first multicentric study conducted in 3 hospitals.
The H526Y mutation in rpoB is a known mutation associated with rifampicin resistance.
Mutation of RNA polymerase β-subunit gene promotes heterogeneous-to-homogeneous conversion of β-lactam resistance in methicillin-resistant Staphylococcus aureus.
The rpoB (N967I) mutation was shown to confer high-dose methicillin tolerance and promote heterogeneous-to-homogeneous conversion of β-lactam resistance.
rpoB
Multidrug-resistant tuberculosis in panama is driven by clonal expansion of a multidrug-resistant Mycobacterium tuberculosis strain related to the KZN extensively drug-resistant M. tuberculosis strain from South Africa.
Rifampicin-resistant Mycobacterium leprae in an elderly leprosy patient in the people's Republic of China.
Mutation in rpoB gene associated with rifampicin resistance
A simple, rapid and economic method for detecting multidrug-resistant tuberculosis.
Detected in 80 isolates
Genome analysis of a transmissible lineage of pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators.
Magnitude of gene mutations conferring drug resistance in mycobacterium tuberculosis isolates from lymph node aspirates in ethiopia.
Primary multidrug-resistant Mycobacterium tuberculosis in 2 regions, Eastern Siberia, Russian Federation.
Mutations in the resistance-determining region of rpoB (codons 511–533) were present in only 79%.
Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis.
Mutations in rpoB confer resistance to rifampicin
Characterization of multi-drug resistant Mycobacterium tuberculosis from immigrants residing in the USA using Ion Torrent full-gene sequencing.
Case 1 and 3
High-resolution melting analysis for molecular detection of multidrug resistance tuberculosis in Peruvian isolates.
Diagnostic Molecular Mycobacteriology in Regions With Low Tuberculosis Endemicity: Combining Real-time PCR Assays for Detection of Multiple Mycobacterial Pathogens With Line Probe Assays for Identification of Resistance Mutations.
Lambda gpP-DnaB Helicase Sequestration and gpP-RpoB Associated Effects: On Screens for Auxotrophs, Selection for Rif(R), Toxicity, Mutagenicity, Plasmid Curing.
Mutations in rpoB gene lead to rifampicin resistance
Correlation between the BACTEC MGIT 960 culture system with Genotype MTBDRplus and TB-SPRINT in multidrug resistant Mycobacterium tuberculosis clinical isolates from Brazil.
Prevalence of rifampicin-resistant Mycobacterium tuberculosis among human-immunodeficiency-virus-seropositive patients and their treatment outcomes.
Mutations in the rpoB gene were associated with rifampicin resistance.
What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping.
Molecular & genetic characteristics of Mycobacterium tuberculosis strains circulating in the southern part of West Siberia.
Performance of MTBDRplus assay in detecting multidrug resistant tuberculosis at hospital level.
Mutations in rpoB gene infer RIF resistance
Rapid Microarray-Based Detection of Rifampin, Isoniazid, and Fluoroquinolone Resistance in Mycobacterium tuberculosis by Use of a Single Cartridge.
Mutations in rpoB, katG, and gyrA were analyzed for their association with resistance to rifampin, isoniazid, and fluoroquinolones.
Direct detection of Mycobacterium tuberculosis rifampin resistance in bio-safe stained sputum smears.
Mutations at codons 526 and 531 in the rpoB gene were associated with rifampin resistance.
Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations.
Mutations in rpoB were identified in isolates that failed to hybridize to rpoB wild-type probes, and some of these mutations were 'disputed' as they did not consistently correlate with rifampicin resistance.
Multi-clonal evolution of multi-drug-resistant/extensively drug-resistant Mycobacterium tuberculosis in a high-prevalence setting of Papua New Guinea for over three decades.
Mutations promoted from gene entry 'rpoB' (model emitted mutations_found inside genes).
Whole-Genome Analysis of Mycobacterium tuberculosis from Patients with Tuberculous Spondylitis, Russia.
Alterations in the Spectrum of Spontaneous Rifampicin-Resistance Mutations in the Bacillus subtilis rpoB Gene after Cultivation in the Human Spaceflight Environment.
mutations in rpoB conferring rifampicin resistance
Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains.
Multi- and Extensively Drug Resistant Mycobacterium tuberculosis in South Africa: a Molecular Analysis of Historical Isolates.
Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania.
compensatory mutation in MDR-TB isolate
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae.
Mutations in the rpoB gene were identified in relapsed leprosy cases and analyzed for their structural and functional effects on rifampin resistance.
Validation of the FluoroType MTBDR Assay for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates.
Altered Mycobacterium tuberculosis Cell Wall Metabolism and Physiology Associated With RpoB Mutation H526D.
Genotyping and molecular detection of multidrug-resistant Mycobacterium tuberculosis among tuberculosis lymphadenitis cases in Addis Ababa, Ethiopia.
detected in 80% of rifampicin-resistant isolates
Experimental platform utilising melting curve technology for detection of mutations in Mycobacterium tuberculosis isolates.
Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms.
Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains.
Mutation in codon 531 (serine to leucine) confers cross-resistance to rifabutin.
Predictable Phenotypes of Antibiotic Resistance Mutations.
Mutation in rpoB reduces susceptibility to rifampin
Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
Detected in two isolates from Mozambique
Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.
Mutations in rpoB RRDR region associated with rifampicin resistance.
Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing.
Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective.
Mutations in rpoB were not associated with rifampicin resistance as determined by phenotypic testing.
Expression Profiles and Mutational Analysis of Daptomycin-Nonsusceptible Staphylococcus aureus Strains
nonsynonymous mutation
Genetic Determinants and Prediction of Antibiotic Resistance Phenotypes in Helicobacter pylori.
Phylogenomic assessment of drug-resistant Mycobacterium tuberculosis strains from Beira, Mozambique.
Mycobacterium tuberculosis Complex Lineage 3 as Causative Agent of Pulmonary Tuberculosis, Eastern Sudan
Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015.
Mutations promoted from gene entry 'rpoB' (model emitted mutations_found inside genes).
Metagenomics of Imported Multidrug-Resistant Mycobacterium leprae, Saudi Arabia, 2017
A Benchtop Automated Sputum-to-Genotype System Using a Lab-on-a-Film Assembly for Detection of Multidrug-Resistant Mycobacterium tuberculosis.
Distribution and Frequency of rpoB Mutations Detected by Xpert MTB/RIF Assay Among Beijing and Non-Beijing Rifampicin Resistant Mycobacterium tuberculosis Isolates in Bangladesh.
Most frequent mutation in both Beijing and non-Beijing isolates
Artificial Intelligence and Machine learning based prediction of resistant and susceptible mutations in Mycobacterium tuberculosis.
Inhibition of RNA Polymerase by Rifampicin and Rifamycin-Like Molecules.
Mutations in the rpoB gene confer resistance to rifampicin.
Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment.
Genome sequence analysis of multidrug-resistant Mycobacterium tuberculosis from Malaysia.
shared variant in twelve strains
Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears.
Mutations in rpoB are associated with rifampicin resistance.
Individualized Treatment of Multidrug-resistant Tuberculosis Using Whole-Genome Sequencing and Expanded Drug-Susceptibility Testing.
Probing the Molecular Mechanism of Rifampin Resistance Caused by the Point Mutations S456L and D441V on Mycobacterium tuberculosis RNA Polymerase through Gaussian Accelerated Molecular Dynamics Simulation.
The D441V mutation in rpoB was shown to confer rifampin resistance.
Substantial improvement of tetraene macrolide production in Streptomyces diastatochromogenes by cumulative drug resistance mutations.
Detection of low-frequency resistance-mediating SNPs in next-generation sequencing data of Mycobacterium tuberculosis complex strains with binoSNP.
Detected in in-vitro datasets with 1% resistant subpopulation.
Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil.
Whole Genome and Transcriptome Sequencing of Two Multi-Drug Resistant Mycobacterium tuberculosis Strains to Facilitate Illustrating Their Virulence in vivo.
Frequency of genomic mutations mediating resistance of Mycobacterium tuberculosis isolates to rifampicin in Northern Morocco.
Mutations in the rpoB gene were identified as the primary cause of rifampicin resistance in Mycobacterium tuberculosis isolates.
Single-nucleotide polymorphisms in a vancomycin-resistant Staphylococcus aureus strain based on whole-genome sequencing.
Emergence of multidrug-resistant Mycobacterium tuberculosis of the Beijing lineage in Portugal and Guinea-Bissau: a snapshot of moving clones by whole-genome sequencing.
Present in GC1 isolates.
Radial Expansion Facilitates the Maintenance of Double Antibiotic Resistances
Detection of heterogeneous vancomycin intermediate resistance in MRSA isolates from Latin America.
Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.
Targeted next-generation sequencing of sputum for diagnosis of drug-resistant TB: results of a national survey in Democratic Republic of the Congo.
Strong Environment-Genotype Interactions Determine the Fitness Costs of Antibiotic Resistance In Vitro and in an Insect Model of Infection.
Mutant ID: 11c
Antimicrobial Susceptibility and Characterization of Resistance Mechanisms of Corynebacterium urealyticum Clinical Isolates.
rpoB
Spoligotype and Drug Susceptibility Profiles of Mycobacterium tuberculosis Complex Isolates in Golestan Province, North Iran.
Correlation of drug resistance with single nucleotide variations through genome analysis and experimental validation in a multi-drug resistant clinical isolate of M. tuberculosis.
Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
Diagnostic Evaluation of Non-Interpretable Results Associated with rpoB Gene in Genotype MTBDRplus Ver 2.0.
Mutations in rpoB gene were identified in non-interpretable (NI) results and confirmed to confer rifampicin resistance through phenotypic drug susceptibility testing (pDST) and sequencing.
Interpretation of Discordant Rifampicin Susceptibility Test Results Obtained Using GeneXpert vs Phenotypic Drug Susceptibility Testing.
mutations in the rifampin resistance-determining region of the rpoB gene
Evolution of Multi-Resistance to Vancomycin, Daptomycin, and Linezolid in Methicillin-Resistant Staphylococcus aureus Causing Persistent Bacteremia.
Exploiting Homoplasy in Genome-Wide Association Studies to Enhance Identification of Antibiotic-Resistance Mutations in Bacterial Genomes.
Mutation in the RDRR region of rpoB leads to resistance to rifampicin.
Rapid Identification of Drug-Resistant Tuberculosis Genes Using Direct PCR Amplification and Oxford Nanopore Technology Sequencing.
Characterisation of drug-resistant Mycobacterium tuberculosis mutations and transmission in Pakistan.
Epidemiological and laboratory characteristics of multidrug-resistant tuberculosis patients in Bhutan, 2015-2019.
Common mutation in rpoB gene
Minos: variant adjudication and joint genotyping of cohorts of bacterial genomes.
Mutations in the rpoB gene's rrdr region are associated with rifampicin resistance.
Evolutionary Instability of Collateral Susceptibility Networks in Ciprofloxacin-Resistant Clinical Escherichia coli Strains.
Hit Compounds and Associated Targets in Intracellular Mycobacterium tuberculosis.
mutations in rpoB known to confer resistance to rifampicin are commonly reported in MDR and XDR Mtb strains
Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study.
Mutation associated with rifampicin resistance.
Isolation of multidrug-resistant (MDR) Mycobacterium bovis from a dog in Korea
Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
Most prevalent mutation
Impact of vancomycin use trend change due to the availability of alternative antibiotics on the prevalence of Staphylococcus aureus with reduced vancomycin susceptibility: a 14-year retrospective study.
A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics.
mutations in rpoB are associated with rifampicin resistance
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
Mutation in rpoB is associated with rifampicin resistance.
Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian clade toward extensively drug resistant tuberculosis.
Predicting antibiotic resistance in complex protein targets using alchemical free energy methods.
Resistant to rifampicin
Evaluation of whole-genome sequence to predict drug resistance of nine anti-tuberculosis drugs and characterize resistance genes in clinical rifampicin-resistant Mycobacterium tuberculosis isolates from Ningbo, China.
Rapid Identification of Drug Resistance and Phylogeny in M. tuberculosis, Directly from Sputum Samples.
Structural Design and Synthesis of Novel Cyclic Peptide Inhibitors Targeting Mycobacterium tuberculosis Transcription.
Mutations in rpoB gene affect rifampicin binding
Characterization of Genetic Variants Associated with Rifampicin Resistance Level in Mycobacterium tuberculosis Clinical Isolates Collected in Guangzhou Chest Hospital, China.
All mutations were experimentally validated in this study.
Deep Amplicon Sequencing Reveals Culture-dependent Clonal Selection of Mycobacterium tuberculosis in Clinical Samples.
The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains-phenotypic, genetic and reference genome characterization.
carried H552N mutation leading to rifampicin resistance
Evaluation of Whole Genome Sequencing-Based Predictions of Antimicrobial Resistance to TB First Line Agents: A Lesson from 5 Years of Data.
Culture-Free Whole Genome Sequencing of Mycobacterium tuberculosis Using Ligand-Mediated Bead Enrichment Method.
Detected in 2 samples classified as rifampicin sensitive by Xpert MTB/RIF.
Metabolic remodeling by RNA polymerase gene mutations is associated with reduced β-lactam susceptibility in oxacillin-susceptible MRSA.
Whole-genome sequencing-based genetic diversity, transmission dynamics, and drug-resistant mutations in Mycobacterium tuberculosis isolated from extrapulmonary tuberculosis patients in western Ethiopia.
The performance of Xpert MTB/RIF and MTBDRplus within a Programmatic setting at TB Laboratory in Rio de Janeiro, Brazil.
The catalogue of Mycobacterium tuberculosis mutations associated with drug resistance to 12 drugs in China from a nationwide survey: a genomic analysis.
Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance.
Escherichia coli rpoB mutants conferring resistance to rifampicin; CARD accession: CARD:3003288
rpoB
MUBII-TB-DB: a database of mutations associated with antibiotic resistance in Mycobacterium tuberculosis.
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
Tuberculosis drug resistance mutation database.
Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing.
Mutations in rpoB are associated with rifampin resistance.
Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.
Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance.
[Metastases to the mediastinal lymph nodes in a series of two-hundred-consecutive operations for primary lung cancer].
Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis.
Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples.
Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus.
Neurosurgical consideration of some features of the cerebral dural sinuses and their tributaries.
Posttraumatic headache and the postconcussion syndrome.
The spectrum of spontaneous rifampin resistance mutations in the rpoB gene of Bacillus subtilis 168 spores differs from that of vegetative cells and resembles that of Mycobacterium tuberculosis.
Bacillus subtilis rpoB mutants conferring resistance to rifampin; CARD accession: CARD:3007073
Mutations in the ss subunit of the Bacillus subtilis RNA polymerase that confer both rifampicin resistance and hypersensitivity to NusG.
Bacillus subtilis rpoB mutants conferring resistance to rifampin; CARD accession: CARD:3007073
High-resolution melting analysis of the single nucleotide polymorphism hot-spot region in the rpoB gene as an indicator of reduced susceptibility to rifaximin in Clostridium difficile.
Clostridioides difficile rpoB with mutation conferring resistance to rifampicin; CARD accession: CARD:3004563
rpoB
In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin.
Clostridioides difficile rpoB with mutation conferring resistance to rifampicin; CARD accession: CARD:3004563
rpoB
Divergent rifamycin susceptibilities of Clostridium difficile strains in Canada and Italy and predictive accuracy of rifampin Etest for rifamycin resistance.
Clostridioides difficile rpoB with mutation conferring resistance to rifampicin; CARD accession: CARD:3004563
rpoB
Antibiotic resistance by high-level intrinsic suppression of a frameshift mutation in an essential gene.
Escherichia coli rpoB mutants conferring resistance to rifampicin; CARD accession: CARD:3003288
Mutations at four distinct regions of the rpoB gene can reduce the susceptibility of Helicobacter pylori to rifamycins.
Helicobacter pylori rpoB mutation conferring resistance to rifampicin; CARD accession: CARD:3007051
Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany.
Helicobacter pylori rpoB mutation conferring resistance to rifampicin; CARD accession: CARD:3007051
Rifampin and rifabutin resistance mechanism in Helicobacter pylori.
Helicobacter pylori rpoB mutation conferring resistance to rifampicin; CARD accession: CARD:3007051
Alternative eradication regimens for Helicobacter pylori infection in Indonesian regions with high metronidazole and levofloxacin resistance.
Helicobacter pylori rpoB mutation conferring resistance to rifampicin; CARD accession: CARD:3007051
Effective therapeutic regimens in two South Asian countries with high resistance to major Helicobacter pylori antibiotics.
Helicobacter pylori rpoB mutation conferring resistance to rifampicin; CARD accession: CARD:3007051
Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
Mycobacterium leprae rpoB mutations conferring resistance to rifampicin; CARD accession: CARD:3003284
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Universal pattern of RpoB gene mutations among multidrug-resistant isolates of Mycobacterium tuberculosis complex from Africa.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Characterization of mutations causing rifampicin and isoniazid resistance of Mycobacterium tuberculosis in Syria.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
High-level rifampin resistance correlates with multiple mutations in the rpoB gene of pulmonary tuberculosis isolates from the Afghanistan border of Iran.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Distribution of rpoB mutations among multidrug-resistant Mycobacterium tuberculosis (MDRTB) strains from Thailand and development of a rapid method for mutation detection.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution?
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Novel mutation detection IN rpoB OF rifampicin-resistant Mycobacterium tuberculosis using pyrosequencing.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
A newly identified 191A/C mutation in the Rv2629 gene that was significantly associated with rifampin resistance in Mycobacterium tuberculosis.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Characterization of rifampin-resistance in pathogenic mycobacteria.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Identification of rifampin-resistant genotypes in Mycobacterium tuberculosis by PCR-reverse dot blot hybridization.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from Brazil.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Mutations in rpoB and katG genes in Mycobacterium isolates from the Southeast of Mexico.
Mycobacterium tuberculosis rpoB with mutations conferring resistance to rifampicin; CARD accession: CARD:3003283
Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.
Staphylococcus aureus rpoB mutants conferring resistance to daptomycin; CARD accession: CARD:3003287
Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus.
Staphylococcus aureus rpoB mutants conferring resistance to rifampicin; CARD accession: CARD:3003285
Rifampicin-resistant RpoB S522L Vibrio vulnificus exhibits disturbed stress response and hypervirulence traits.
Vibrio vulnificus rpoB mutants conferring resistance to rifampin; CARD accession: CARD:3007794
Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii.
rpoB
Rifamycin Resistance in Clostridium difficile Is Generally Associated with a Low Fitness Burden.
rpoB
Characterization of the impact of rpoB mutations on the in vitro and in vivo competitive fitness of Clostridium difficile and susceptibility to fidaxomicin.
rpoB
Improved long-acting fertility regulating agents: what are the problems?
rpoB
Characterization of a clinical Clostridioides difficile isolate with markedly reduced fidaxomicin susceptibility and a V1143D mutation in rpoB.
rpoB
In vivo emergence of a still uncommon resistance to fidaxomicin in the urgent antimicrobial resistance threat Clostridioides difficile.
rpoB
Antimicrobial susceptibility and molecular characterisation using whole-genome sequencing of Clostridioides difficile collected in 82 hospitals in Japan between 2014 and 2016.
rpoB
Genomic Diversity and Antimicrobial Resistance of Haemophilus Colonizing the Airways of Young Children with Cystic Fibrosis.
rpoB
Rifampicin Resistance Associated with rpoB Mutations in Neisseria gonorrhoeae Clinical Strains Isolated in Austria, 2016 to 2020.
rpoB
mutations in rpoB are associated with rifampicin resistance
Description of new mutations in the rpoB gene in rifampicin-resistant Neisseria meningitidis selected in vitro in a stepwise manner.
rpoB
Effects of injury on [3H]putrescine uptake by types I and II cells in rat lung slices.
rpoB
Convergent Evolution Driven by Rifampin Exacerbates the Global Burden of Drug-Resistant Staphylococcus aureus.
rpoB
All mutations were validated via reconstruction in an isogenic background and MIC testing.
The oxygen radical disease in neonatology.
rpoB
Evolving MRSA: High-level β-lactam resistance in Staphylococcus aureus is associated with RNA Polymerase alterations and fine tuning of gene expression.
rpoB
Rifampicin resistance in Staphylococcus epidermidis: molecular characterisation and fitness cost of rpoB mutations.
rpoB
Effect of chronic metabolic acidosis on ammonia production from L-glutamine in microdissected rat nephron segments.
rpoB
Global Expansion of Linezolid-Resistant Coagulase-Negative Staphylococci.
rpoB
In Vitro Activity of Rifampin, Rifabutin, Rifapentine, and Rifaximin against Planktonic and Biofilm States of Staphylococci Isolated from Periprosthetic Joint Infection.
rpoB
Characterization of new staphylococcal cassette chromosome mec (SCCmec) and topoisomerase genes in fluoroquinolone- and methicillin-resistant Staphylococcus pseudintermedius.
rpoB
Linking epidemiological and genomic data in cases of enteric fever in England to inform clinical management and public health action.
Mutations in rpoB confer resistance to rifampicin.
Drug resistance profiles and related gene mutations in slow-growing non-tuberculous mycobacteria isolated in regional tuberculosis reference laboratories of Iran: a three year cross-sectional study.
Efflux pumps positively contribute to rifampin resistance in rpoB mutant Mycobacterium tuberculosis.
Mutations in rpoB gene were associated with increased rifampin resistance.
Evaluation of genotype MTBDRplus assay for rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis clinical isolates from Pakistan.
Compensatory mutations are associated with increased in vitro growth in resistant clinical samples of Mycobacterium tuberculosis.
mutations associated with rifampicin resistance
Diverse impacts of different rpoB mutations on the anti-tuberculosis efficacy of capreomycin.
Mutations at codon 435 (D435G, D435V) conferred increased CAP tolerance, while mutations at codon 445 (H445Y, H445R) enhanced CAP bactericidal effect.
Novel Chemical Scaffolds for Inhibition of Rifamycin-Resistant RNA Polymerase Discovered from High-Throughput Screening.
Mutations in the rpoB gene were analyzed for their impact on rifampin resistance.
A comprehensive evaluation of a novel targeted-sequencing workflow for Mycobacterium species identification and anti-tuberculosis drug-resistance detection.
missed by TB Pro assay
Genomic Analysis of Multidrug-Resistant Mycobacterium tuberculosis Strains From Patients in Kazakhstan.
Mutation found in all eight MDR-TB isolates.
Signatures of Selection at Drug Resistance Loci in Mycobacterium tuberculosis.
dominant RIF resistance mutation
Whole Genome Sequencing of Drug Resistant and Drug Susceptible Mycobacterium tuberculosis Isolates From Tigray Region, Ethiopia.
major resistance mutation
Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam Antibiotics.
Mutation in rpoB associated with rifampin resistance and MDR level drug-resistance.
Dynamic PET-facilitated modeling and high-dose rifampin regimens for Staphylococcus aureus orthopedic implant-associated infections.
missense mutation
Consensus numbering system for the rifampicin resistance-associated rpoB gene mutations in pathogenic mycobacteria.
Mutations in the rpoB gene are associated with rifampicin resistance in Mycobacterium tuberculosis, Mycobacterium leprae, and Mycobacterium kansasii.
Mycobacterium tuberculosis Drug Resistance and Transmission among Human Immunodeficiency Virus-Infected Patients in Ho Chi Minh City, Vietnam.
Prospective Comparative Evaluation of the Xpert MTB/RIF and Xpert MTB/RIF Ultra Assays for Detecting Mycobacterium tuberculosis and Rifampin Resistance in High-resource, Intermediate-burden Settings.
Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance.
Disputed mutation
Encapsulating bacteria in agarose microparticles using microfluidics for high-throughput cell analysis and isolation.
Pervasive genotype-by-environment interactions shape the fitness effects of antibiotic resistance mutations.
All mutations are in the rpoB gene, which encodes the beta subunit of RNA polymerase.
Environmental pleiotropy and demographic history direct adaptation under antibiotic selection.
Drug-resistant TB prevalence study in 5 health institutions in Haiti.
Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools.
Mutations in rpoB were identified in strains resistant to rifampicin.
SAM-TB: a whole genome sequencing data analysis website for detection of Mycobacterium tuberculosis drug resistance and transmission.
Nanopore-based targeted next-generation sequencing (tNGS): A versatile technology specialized in detecting low bacterial load clinical specimens.
All mutations were identified in the rpoB gene, with 20 located in the rifampicin resistance-determining region (RRDR) and one outside the RRDR.
Diminishing Returns From Beneficial Mutations and Pervasive Epistasis Shape the Fitness Landscape for Rifampicin Resistance in Pseudomonas aeruginosa.
Mutations in rpoB gene confer rifampicin resistance.
Testing the role of genetic background in parallel evolution using the comparative experimental evolution of antibiotic resistance.
Mutations in rpoB were responsible for rifampicin resistance
Environmental Dependence of Competitive Fitness in Rifampin-Resistant rpoB Mutants of Bacillus subtilis.
Some mutations were found to have varying effects on fitness depending on the growth environment.
Molecular detection of Mycobacterium tuberculosis sensitivity to rifampicin and isoniazid in South Gondar Zone, northwest Ethiopia.
RIF-resistance conferred by absence of rpoB WT7 without MUT3.
Antimicrobial Resistance in Rhodococcus equi.
Whole genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates collected in the Czech Republic, 2005-2020.
Light Forge: A Microfluidic DNA Melting-based Tuberculosis Test.
Mutations in the rpoB gene were identified as responsible for rifampicin resistance in Mycobacterium tuberculosis.
New mutations and horizontal transfer of rpoB among Rifampin-Resistant Streptococcus pneumoniae from four Spanish hospitals.
Mutations in rpoB were identified as the cause of rifampin resistance in Streptococcus pneumoniae.
Successful Treatment of a Multidrug-Resistant Tuberculosis Patient with a Negative Xpert MTB/RIF Test for Rifampicin-Resistant Tuberculosis in Guizhou Province of China: A Case Report.
Mutation outside the RIF resistance-determining region (RRDR) not detectable by Xpert MTB/RIF assay
Modified methicillin-resistant Staphylococcus aureus detected in neonatal intensive care patients.
An A574T substitution in RpoB was found in the resistant isolate from infant 2.
The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.
Mutations in rpoB were analyzed for their effect on rifampin resistance.
Phenotypic and Genotypic Comparison of Antimicrobial-Resistant Variants of Escherichia coli and Salmonella Typhimurium Isolated from Evolution Assays with Antibiotics or Commercial Products Based on Essential Oils.
Mutations in rpoB gene associated with rifampicin resistance
Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study.
The rpoB mutation Ser450Leu was identified as a rifampicin resistance-conferring mutation in the study.
Redefining MTBDRplus test results: what do indeterminate results actually mean?
mutations in rpoB confer resistance to rifampicin
Fluoromycobacteriophages for rapid, specific, and sensitive antibiotic susceptibility testing of Mycobacterium tuberculosis.
Discordance in genotypic and phenotypic drug susceptibility results: time to reconsider critical concentration of rifampicin.
Commonest mutation
A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics.
Mutation in rpoB gene was observed in all nine evolved colonies.
Antibacterial and antivirulence effect of 6-N-hydroxylaminopurine in Listeria monocytogenes.
Mutations in rpoB were identified as a result of 6-N-HAP treatment, leading to rifampicin resistance.
Genomic epidemiological analysis identifies high relapse among individuals with recurring tuberculosis and provides evidence of recent household-related transmission of tuberculosis in Ghana.
Mutations detected in multiple cases.
Whole Genome Sequencing of Mycobacterium tuberculosis under routine conditions in a high-burden area of multidrug-resistant tuberculosis in Peru.
c-di-AMP signaling plays important role in determining antibiotic tolerance phenotypes of Mycobacterium smegmatis.
Mutation in the rifampicin resistance-determining region (RRDR) of rpoB leads to rifampicin resistance.
Innovative approach for improvement of an antibiotic-overproducing industrial strain of Streptomyces albus.
The rpoB mutations may affect antibiotic production by altering the initiation of secondary metabolism.
Multidrug-resistant toxigenic Corynebacterium diphtheriae sublineage 453 with two novel resistance genomic islands.
Whole-genome sequencing reveals transmission pattern and drug resistance of Mycobacterium tuberculosis intra- or inter-hosts.
Applying whole genome sequencing to predict phenotypic drug resistance in Mycobacterium tuberculosis: leveraging 20 years of nationwide data from Denmark.
Deciphering the population dynamics and drug-resistance characteristics of extrapulmonary tuberculosis: genomic and clinical insights from a Chinese hospital.
Transmission dynamics of drug-resistant tuberculosis in Ningbo, China: an epidemiological and genomic analysis.
First-line drug resistance profiling of Mycobacterium tuberculosis: a machine learning approach.
Drug resistant Mycobacterium tuberculosis strains have altered cell envelope hydrophobicity that influences infection outcomes in human macrophages.
Mutations in rpoB are associated with rifampicin resistance in MDR and pre-XDR strains.
In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: microbiology profiling studies with staphylococci and streptococci.
Mutation in rpoB gene leads to rifampin resistance.
In Vitro Activity of Dalbavancin against Refractory Multidrug-Resistant (MDR) Staphylococcus aureus Isolates.
Mutations in rpoB were associated with rifampicin resistance and correlated with VISA/hVISA emergence.
Genome-based assessment of antimicrobial resistance reveals the lineage specificity of resistance and resistance gene profiles in Riemerella anatipestifer from China.
Molecular epidemiology of Clostridioides difficile in companion animals: Genetic overlap with human strains and public health concerns.
Detected in one isolate.
Genomic evolution and virulence association of Clostridioides difficile sequence type 37 (ribotype 017) in China.
Mutations in rpoB associated with rifampicin resistance
Phenotypic drug susceptibility characterization and clinical outcomes of tuberculosis strains with A-probe mutation by GeneXpert MTB/RIF.
Mutations in rpoB gene associated with rifampicin resistance
Epistasis decreases with increasing antibiotic pressure but not temperature.
Mutations in rpoB confer resistance to rifampicin by altering the binding site.
Lytic phages obscure the cost of antibiotic resistance in Escherichia coli.
Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs.
Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimen.
Potential for adaptation overrides cost of resistance.
Molecular epidemiology of Mycobacterium tuberculosis complex in the Volta Region of Ghana.
Epidemiology of Staphylococcus haemolyticus nosocomial bacteraemia in neonatal intensive care units, France, 2019 to 2023: predominance of the ST29 (CC3) multidrug-resistant lineage.
Genomic analysis of a multidrug-resistant Staphylococcus epidermidis isolate BPH0662 reveals insights into hospital adaptation and resistance mechanisms
associated with rifampicin resistance
Deletion of rifampicin-inactivating mono-ADP-ribosyl transferase gene of Mycobacterium smegmatis globally altered gene expression profile that favoured increase in ROS levels and thereby antibiotic resister generation.
Mutations in the RRDR of rpoB conferred rifampicin resistance in arr-KO and WT strains.
Development of multiplex assay for rapid characterization of Mycobacterium tuberculosis.
Mutation in rpoB codon 176 (C->T) leads to rifampin resistance.
Multidrug-resistant tuberculosis in Port-au-Prince, Haiti.
Mutations in the rpoB gene were associated with rifampin resistance.
A molecular platform for the diagnosis of multidrug-resistant and pre-extensively drug-resistant tuberculosis based on single nucleotide polymorphism mutations present in Colombian isolates of Mycobacterium tuberculosis.
Detection of Rifampin-Resistant Mycobacterium tuberculosis in Sputa by Nested PCR-Linked Single-Strand Conformation Polymorphism and DNA Sequencing.
Mutations at codon 526 (His 526 -> Tyr) and 531 (Ser 531 -> Leu) were identified.
Mycobacterium tuberculosis Beijing genotype resistance to transient rifampin exposure.
Mutants were detected in the rpoB gene, which is associated with rifampin resistance.
Spread of Drug-Resistant Mycobacterium tuberculosis Strains of the Beijing Genotype in the Archangel Oblast, Russia.
The 531 TCG→TTG mutation was predominant among strains of the Beijing genotype.
Rifampin Resistance in Mycobacterium kansasii Is Associated with rpoB Mutations
Mutations in codons 513, 526, and 531 have previously been described in rifampin-resistant M. tuberculosis isolates.
Unexpected Genomic and Phenotypic Diversity of Mycobacterium africanum Lineage 5 Affects Drug Resistance, Protein Secretion, and Immunogenicity.
Plasmid-based controls to detect rpoB mutations in Mycobacterium tuberculosis by quantitative polymerase chain reaction-high-resolution melting.
C531T mutation in the rifampicin resistance-determining region of rpoB
Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
Synonymous mutation in rpoB gene
Methicillin-resistant Staphylococcus aureus outbreak in a Dutch equine referral clinic.
Antimicrobial Resistance Profiling and Phylogenetic Analysis of Neisseria gonorrhoeae Clinical Isolates From Kenya in a Resource-Limited Setting.
Real-time PCR and high-resolution melt analysis for rapid detection of Mycobacterium leprae drug resistance mutations and strain types.
Detected in clinical strains
Rifampin-resistant meningococcal disease.
Mutations in the RNA polymerase β subunit (rpoB) gene were found in isolates from each rifampin-resistant case-patient.
Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed rpoB Mutations and Discordant Susceptibility Phenotypes.
Mutant associated with low-level rifampicin resistance
The MTB/MDR ELITe MGB(®) Kit: Performance Assessment for Pulmonary, Extra-Pulmonary, and Resistant Tuberculosis Diagnosis, and Integration in the Laboratory Workflow of a French Center.
The rpoB L452P mutation was identified in a strain with low-level rifampicin resistance that was not detected by phenotypic AST.
Predicting rifampicin resistance in Mycobacterium tuberculosis using machine learning informed by protein structural and chemical features.
mutations in rpoB are associated with rifampicin resistance
Anti-tuberculosis drug resistance in Slovakia, 2018-2019: The first whole-genome epidemiological study.
Comparative Performance of Line Probe Assay (Version 2) and Xpert MTB/RIF Assay for Early Diagnosis of Rifampicin-Resistant Pulmonary Tuberculosis.
Mutation detected in samples with discordant rifampicin susceptibility results.
Mutators can drive the evolution of multi-resistance to antibiotics.
Adaptive Resistance Mutations at Suprainhibitory Concentrations Independent of SOS Mutagenesis.
Single point mutation in the rpoB gene located in the rifampicin resistance determining region (RRDR) was identified in resistant clones.
Transformation of Rickettsia prowazekii to rifampin resistance.
The mutation was identified in a rifampin-resistant mutant and confirmed through sequencing.
A CRISPR-guided mutagenic DNA polymerase strategy for the detection of antibiotic-resistant mutations in M. tuberculosis.
Mutation I70M in rpoB was confirmed to confer rifampicin resistance.
Diagnostic performance of the Sanity 2.0 assay to detect resistance to rifampicin, isoniazid, and fluoroquinolones in tuberculosis.
Detected in discrepant cases where the assay reported susceptible but WGS identified the mutation.
Engineered Mycobacteriophage TM4::GeNL Rapidly Determines Bedaquiline, Pretomanid, Linezolid, Rifampicin, and Clofazimine Sensitivity in Mycobacterium tuberculosis Clinical Isolates.
Mutations in rpoB are associated with rifampicin resistance.
Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic.
Mutations in rpoB are commonly associated with rifampicin resistance.
Transition bias influences the evolution of antibiotic resistance in Mycobacterium tuberculosis.
mutation in rpoB leading to rifampicin resistance
Drug resistant Mycobacterium tuberculosis in Oman: resistance-conferring mutations and lineage diversity.
Nosocomial transmission of Clostridium difficile ribotype 027 in a Chinese hospital, 2012-2014, traced by whole genome sequencing.
Mutation in rpoB gene associated with fluoroquinolone resistance
Globally diverse Mycobacterium tuberculosis resistance acquisition: a retrospective geographical and temporal analysis of whole genome sequences.
False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load.
Silent mutation in rpoB codon T508 was identified in some false-positive cases.
Establishment and evaluation of an overlap extension polymerase chain reaction technique for rapid and efficient detection of drug-resistance in Mycobacterium tuberculosis.
Genomic characterization of MDR/XDR-TB in Kazakhstan by a combination of high-throughput methods predominantly shows the ongoing transmission of L2/Beijing 94-32 central Asian/Russian clusters.
Horizontal Gene Transfer, Fitness Costs and Mobility Shape the Spread of Antibiotic Resistance Genes into Experimental Populations of Acinetobacter Baylyi.
Source of the Fitness Defect in Rifamycin-Resistant Mycobacterium tuberculosis RNA Polymerase and the Mechanism of Compensation by Mutations in the β' Subunit.
The βS450L mutation is associated with rifampin resistance and is the most prevalent mutation in clinical isolates.
Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania.
Mutation in rpoB gene associated with rifampicin resistance.
Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis.
Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe.
Variant S531L in rpoB gene causes resistance to rifampicin.
Molecular epidemiology of Mycobacterium tuberculosis, Buenos Aires, Argentina.
Differences in transneuronal transport of horseradish peroxidase conjugated wheat germ agglutinin in the visual system: marmoset monkey and guinea pig compared.